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Abstract 
Deep brain stimulation (DBS) therapy is used for managing symptoms associated with a 
growing number of neurological disorders. One of the primary challenges with delivering 
this therapy, however, continues to be accurate neurosurgical targeting of the DBS lead 
electrodes and post-operative programming of the stimulation settings. Two approaches 
for addressing targeting have been advanced in recent years. These include novel DBS 
lead designs with more electrodes and computational models that can predict cellular 
modulation during DBS. Here, we developed a personalized computational modeling 
framework to (1) thoroughly investigate the electrode design parameter space for current 
and future DBS array designs, (2) generate and evaluate machine learning feature sets for 
semi-automated programming of DBS arrays, (3) study the influence of model 
parameters in predicting behavioral and electrophysiological outcomes of DBS in a 
preclinical animal model of Parkinson’s disease, and (4) evaluate feasibility of a novel 
endovascular targeting approach to delivering DBS therapy in humans. These studies 
show how independent current controlled stimulation with advanced machine learning 
algorithms can negate the need for highly dense electrode arrays to shift, steer, and sculpt 
regions of modulation within the brain. Additionally, these studies show that while 
advanced and personalized computational models of DBS can predict many of the 
behavioral and electrophysiological outcomes of DBS, there are remaining 
inconsistencies that suggest there are additional physiological mechanisms of DBS that 
are not yet well understood. Finally, the results show how computational models can be 
beneficial for prospective development of novel approaches to neuromodulation prior to 
large-scale preclinical and clinical studies.      
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 2 
1. Introduction 
1.1.Deep brain stimulation 
Deep brain stimulation therapy is used for managing symptoms associated with a 
growing number of neurological and cognitive disorders, particularly in cases where 
medication is ineffective or not well tolerated. In the United States, several brain areas 
have been approved or been granted a humanitarian device exemption (HDE) by the 
Food and Drug Administration (FDA) as targets for DBS therapy to treat the symptoms 
of essential tremor (ET) [1], Parkinson’s disease (PD) [2], dystonia [3], and obsessive-
compulsive disorder (OCD) [4]. To date, over 120,000 DBS leads have been implanted 
and DBS surgery has become common practice for treating subsets of patients suffering 
from these disorders.    
DBS therapy was originally inspired by the practice of lesioning tissue within the globus 
pallidus internus (GPi) or the ventrolateral intermedus (Vim) nucleus of the thalamus for 
treating patients with severe idiopathic PD or ET, respectively [5,6]. While the 
mechanisms of DBS are not yet completely understood, perhaps the most elegant theory 
states that electrical stimulation acts as a reversible and adjustable information-lesion, 
thereby producing a similar therapeutic effect to anatomical lesioning [7,8]. Motivated by 
this hypothesis, a subset of putatively therapeutic DBS targets currently under 
investigation include those already recognized as lesion targets. For example, the anterior 
limb of the internal capsule (ALIC) for treatment resistant OCD [9] and the anterior 
cingulate for treatment resistant depression (TRD) [10]. Other putatively therapeutic DBS 
targets have been identified through studies using electrophysiology to relate stimulation 
of a particular brain region to a particular behavior (e.g. stimulation of the ventromedial 
and lateral hypothalamus for eating disorders [11]) or through serendipitous discovery 
(e.g. stimulation of the fornix for memory disorders [12]). Investigations into the safety 
and efficacy of delivering therapeutic electrical stimulation to numerous brain targets are 
currently underway and include both cortical and deep brain (Table 1) structures. 
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Table 1. Conditions and respective DBS targets: current and investigational. 
Clinical disorder Targeted neural region [13–18] 
Parkinson’s disease STNa, GPia, PPN, CM/pf-Th 
Essential tremor Vim-Th
a
, CM/pf-Th 
Dystonia GPi
b
, STN
b
 
Obsessive-compulsive disorder ALIC
b
, NAc, VC/VS, ITP, STN 
Tourette syndrome GPi, CM/pf-Th 
Treatment resistant depression SgCwm, VS, STN, GPi, ITP, NAc, ALIC, LH 
Addiction NAc 
Cluster headache pHyp 
Chronic pain PAG/PVG, VPL/VPM-Th, Vc-Th 
Obesity/anorexia nervosa VMH, latHyp, NAc 
Alzheimer’s disease Fornix 
Epilepsy CM/pf-Th, AN-Th, STN, hippocampus 
Disorder of consciousness LN-Th 
Aggressive behavior Hypothalamus 
a
FDA approved, 
b
Humanitarian device exemption 
ALIC=anterior limb of the internal capsule, AN-Th=anterior nucleus of the thalamus, 
CM/pf-Th=centromedian/parafasicularis nucleus of the thalamus, GPi=globus pallidus 
internus, ITP=inferior thalamic peduncle, latHyp=lateral hypothalamus, LH=lateral 
habenula, LN-Th=lateral nucleus of the thalamus, NAc=nucleus accumbens, 
PAG/PVG=periaqueductal gray/periventricular gray, pHyp=posterior hypothalamus, 
SgCwm=subgenual cingulate white matter, STN=subthalamic nucleus, Vc-Th=ventralis 
caudalis nucleus of the thalamus, VC/VS=ventral capsule/ventral striatum, Vim-
Th=ventrolateral intermedus nucleus of the thalamus, VMH=ventromedial 
hypothalamus, VPL/VPM=ventral posterolateral/ventro-posteromedial nucleus of the 
thalamus, VS=ventral striatum. 
1.2.Challenges associated with DBS 
Deep brain stimulation is a procedure that is considered on an individual basis. The 
process generally begins with referral of a patient to a DBS surgical center by a patient’s 
primary physician who, in the case of PD or ET, may be a neurologist or movement 
disorders specialist. A patient’s primary physician and a neurosurgeon will generally 
work closely with the patient to consider potential costs and benefits of neurosurgical 
implantation of a DBS system. Patient selection criteria for DBS depend on the disorder 
being treated; however, consideration generally includes two key factors: potential 
therapeutic benefit and ability to tolerate surgery.  
1.2.1. Therapeutic benefit and directional steering 
 4 
Assessing the potential therapeutic benefit can be difficult, particularly in the case of 
novel DBS applications. Guidelines for assessing the potential therapeutic benefit have 
been proposed in the literature and continue to evolve as clinicians gain more experience 
using DBS for the treatment of a wide variety of brain disorders [19–22]. In the most 
common use-case for DBS, STN or GPi DBS for Parkinson’s disease, the best predictor 
of therapeutic benefit is considered an excellent initial response to the drug, levodopa 
[23]. Within this subset of potential therapeutic responders, however, DBS efficacy is 
highly dependent on lead trajectory and placement [24]. 
The success of DBS therapy relies heavily on accurate electrode placement within the 
brain [25]. The stereotactic technique is used to deliver a DBS lead along a preplanned 
implantation trajectory to the correct depth. This technique has been advanced over 
several decades by high-precision instruments and improved medical imaging. However 
pre-operative imaging is commonly confounded by intra-operative brain shift [26–28]. 
Accurate lead placement facilitates precise electrical stimulation of the targeted brain 
region and avoidance of brain regions known to induce side-effects. The size of these 
anatomical targets, and their proximity to brain regions known to induce side-effects, 
dictate that leads be placed with millimeter-scale accuracy [29]. Attaining this level of 
accuracy is particularly difficult in the case of DBS because deep brain structures are 
targeted using implant trajectories that originate from the cranial surface. Therefore, 
small deviations from the surgical plan can result in large discrepancies between the 
planned final lead location and the actual lead location. Evidence of suboptimal lead 
placement can be gathered during surgery using intraoperative microelectrode recordings 
(MER) and electrical stimulation. This information can then be used to determine a new 
lead trajectory and allow for correction without additional surgical procedures. Following 
surgery, current steering may be used to compensate for small errors in final lead 
placement by adjusting stimulation parameters.  
Currently, the process of DBS therapy is most commonly delivered using the Medtronic 
DBS system. The DBS leads currently offered by Medtronic consist of a stack of four 1.5 
mm tall cylindrical shell electrodes distributed along a 1.27 mm diameter lead with 
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electrode separation of 1.5 (model 3387) or 0.5 (model 3389). Such leads provide the 
opportunity to select the best electrode for stimulation in a manner that can compensate 
for leads that are placed more deep or shallow than planned [30–33]. In the case of PD, 
the optimal stimulation configuration is selected for a patient through monopolar review, 
whereby a clinician will systematically increase the stimulation amplitude using each 
electrode while assessing therapeutic benefit and side-effects [34]. If no optimal 
stimulation configuration is found using monopolar settings a clinician may explore 
bipolar settings as well. This programming method works well in the case of PD or ET 
where many of the motor signs and side-effects present quickly in response to 
stimulation, on the order of several seconds to minutes. However, the therapeutic effects 
of DBS on dystonia, for example, may take weeks to months to manifest and therefore 
make selection of stimulation parameters much more difficult [35].  
Medical software and computational models made specifically for DBS applications have 
the potential to assist clinicians in both surgical planning and stimulation parameter 
selection. Such software provides the ability to plan surgical trajectories using patient-
specific medical imaging data and to better select stimulation parameters by estimating a 
volume of tissue activated (VTA) using any number of electrodes and stimulation 
amplitudes. While such computational tools are useful for programming conventional 
DBS, they will become necessary for stimulation parameter selection as advancements in 
lead fabrication techniques enable DBS leads with more electrodes and more complex 
stimulation configuration possibilities. Such computational tools will also become 
necessary for selection of stimulation parameters for clinical indications in which DBS 
does not respond quickly to electrical stimulation.    
As of 2016, new DBS lead designs with novel and potentially clinically advantageous 
features have been granted the European CE Mark and one has gained FDA approval for 
sale in US markets. Several of these novel designs include electrodes distributed radially 
around the lead, which allows for directional current steering in two dimensions rather 
than one. For this reason, these deep brain stimulation arrays (DBSA) are anticipated to 
improve patient outcomes by allowing clinicians to better customize stimulation to 
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individual patients and better compensate for suboptimal DBS lead placement. However, 
selection of stimulation parameters using leads with more electrodes will require new 
approaches, as will be shown in the subsequent chapters, leveraging predictive modeling 
to help manage the increased number of stimulation options.  
1.2.2. Surgical tolerance and vascular complications 
In its current form, DBS has proven to be a safe and reliable treatment option for many 
patients; however, complications associated with craniotomy, meningeal damage, micro 
bleeds, ventricular penetration, and risk of severe hemorrhage disqualify many patients 
from surgical candidacy. These risks can be partially mediated by the use of high-
precision instruments and improved medical imaging, but can be confounded by intra-
operative brain shift [26–28], which may lead to unanticipated vascular damage and 
breaching the ventricular wall during MER and lead implantation [36]. Risk factors for 
the occurrence of hemorrhage in DBS surgery have been studied extensively and 
correlated with the use of MER, sulcal incursion, and breaching the ventricular walls 
[37–41]. The reported symptomatic effects of clearly observable vascular events 
following DBS surgery include increased relative risk of post-operative seizure [42], 
permanent neurological deficit [43], post-operative confusion [44], and subsequent 
extended hospital stays [45]. Reports on the symptomatic effects of small bleeds exist, 
but remain difficult to interpret as small bleeds are likely underreported [38] due to a lack 
of blood-sensitive pre- and post-operative imaging [36,46]. 
Patient factors shown to be correlated with increased risk of hemorrhage include 
hypertension [39,47], age [40,48], male gender [49], and vascular malformation [50]. 
These rates have also been shown to vary across target [51,52] and may relate to lead 
trajectory and target proximity to large blood vessels. For example, GPi DBS for PD 
carries a higher risk of hemorrhage than STN DBS [51–54] and this may be related to the 
close proximity of the A1 segment of the anterior cerebral arteries (ACA) to the ventral 
border of GPi. Alternatively, reports of cognitive complications for STN DBS are higher 
in comparison to GPi DBS and are correlated with the use of transventricular lead 
implantation trajectories [44]. 
 7 
Patient factors associated with hemorrhage and comorbidities such as dementia are 
utilized as exclusion criteria during prescreening for DBS surgical eligibility [55–59]. It 
is impossible to know the number of patients excluded from surgery due to risk factors 
associated with stereotactic lead implantation; however, one study showed that 30% of 
patients deemed eligible for STN DBS surgery by prescreening were later excluded, with 
reasons pertaining to neuropsychological disorders (48.3%) cited as the most common 
reason [56]. The same study found that 10% of excluded patients were poorly motivated 
for surgery, while a later survey assessment of patient receptivity to DBS for ET found 
that nearly two-thirds of patients interviewed would not consider undergoing surgery 
[60]. These studies indicate that risk factors, exclusion criteria, and patient reservations 
associated with transcranial lead implantation may leave a large population of 
medication-refractory patients underserved by DBS therapy [61]. The development of 
new and complementary techniques for delivering DBS may help to expand the patient 
population served by DBS. Technologies that are of particular interest include 
endovascular approaches (discussed in chapter 4) that enable electrodes to be implanted 
without penetrating brain tissue and microvasculature [62–64]. 
1.3.Computational modeling of DBS 
Computational models of DBS generate a prediction of cellular activation during 
stimulation, which are represented spatially by defining a volume of tissue activated or by 
activation profile curves that are brain region specific. These models provide a platform 
to study DBS therapy in a manner that complements experimental studies. In the past two 
decades computational models have been used in studies to explore mechanisms of DBS 
[8,65], to guide surgical planning and patient programing [66–69], and to evaluate novel 
DBS lead designs [70–72]. Advancements in model complexity and available 
computational power have improved the usefulness of these models by enabling the 
creation of individualized or ‘personalized’ models of DBS. These personalized models 
rely on medical imaging data to reflect subtle aspects of neural anatomy and generate 
model solutions that are specific to individual patients. Using anatomical medical 
imaging data, models of DBS span the macro and micro scale by combining a patient-
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specific volume conductor model of the brain with multi-compartment cell models 
populated throughout brain regions that are segmented and reconstructed. 
1.3.1. Volume conductor models of the brain 
Volume conductor models of the brain incorporate electrical properties of tissue and 
provide the means to solve for time and spatially dependent electric potential in the brain 
during stimulation. These models rely on the governing equations of electromagnetic 
phenomena, Maxwell’s equations. Stimulation waveforms used in DBS have a spectrum 
with minimal power above 10 kHz allowing for the use of a simplified set of equations 
known as the quasistatic formulation [73]:  
Law of conservation of charge:  ∇ ∙ 𝐽 = 0     (1) 
Gauss’ law:     ∇ ∙ 𝐸 =
𝜌
𝜀
     (2) 
Ohm’s law:     𝐽 = 𝜎𝐸     (3) 
Electric field by definition:  𝐸 = −∇Φ     (4) 
where J is the current density,  E is the electric field, Φ is the scalar electric potential, σ is 
the conductivity, ρ is the charge density, ɛ is the permittivity. From the quasistatic 
formulation, assuming an infinite and homogenous medium, the domain equation for 
simple point source volume conductor models can be derived and used to calculate 
electric potential in tissue during stimulation. 
For a monopolar source:   Φ =
𝐼
4𝜋𝜎𝑟
     (5) 
For a bipolar source:    Φ =
𝐼
4𝜋𝜎
(
1
𝑟1
−
1
𝑟2
)    (6) 
where r is the distance between the point source and the point where electric potential is 
measured. For bipolar sources, the subscript 1 and 2 represent the anodic and cathodic 
point sources, respectively. These point source models were utilized in early modeling 
studies of DBS [74,75] and under specific conditions, provide valid estimates of electric 
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potential in tissue during microelectrode stimulation [76] and DBS [77]. Point source 
models can be expanded upon to include multiple sources, anisotropic homogenous 
mediums, and semi-infinite inhomogeneous mediums. However, point source models 
cannot be used to compare different lead designs, represent anatomically correct 
brain/head models, or incorporate anatomically correct inhomogeneous and anisotropic 
tissue properties. Modeling of these aspects require the use of numerical techniques such 
as finite element analysis (FEA) or boundary element analysis and rely on discretized 
representations of the brain and DBS lead to solve a more generalized domain equation, 
which can be derived from the quasistatic formulation and used to solve for electric 
potential in tissue during stimulation. Using Eqs. 1, 3, and 4, the domain equation takes 
the following form: 
∇J = ∇ ∙ 𝜎E = ∇ ∙ 𝜎∇Φ = 0    (7) 
and is solved using FEA in the context of applied boundary conditions. Expanding the 
conductivity parameter to incorporate capacitive and dispersive tissue properties results 
in the formulation of the time-harmonic electro-quasistatic equation: 
∇ ∙ [𝜎(𝜔) + 𝑗𝜔𝜀0𝜀𝑟(𝜔)]∇Φ = 0   (8) 
where ω is angular frequency, j is the imaginary unit, ɛ0 is the permittivity of free space 
(8.85 x 10
-12
 F/m), ɛr is relative permittivity. 
1.3.2. Inhomogeneous and anisotropic electrical properties of brain tissue 
Accurate calculation of the voltage in tissue during electrical stimulation is highly 
dependent on accurate representations of the electrical properties of tissue. Early studies 
investigating the electrical properties of tissue demonstrated that conductivity and relative 
permittivity in brain tissue are frequency dependent [78] and vary for different tissues 
within the brain [79,80]. In a series of journal articles published in 1996 by Gabriel et al., 
the authors performed a comprehensive analysis of electrical properties of various 
biological tissues including brain gray matter, brain white matter, cerebrospinal fluid, and 
blood. Gabriel et al. experimentally characterized the electrical properties of these tissues 
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[81], performed a comprehensive meta-analysis of literature on the subject [82], and 
generated a mathematical model from which conductivity and relative permittivity of the 
investigated tissues can be calculated [83]. 
The Gabriel dispersion equation provides the means to generate detailed model of the 
brain that is inhomogeneous and dispersive. However, it does not accurately represent 
anisotropy, which exists in gray matter and is prominent in white matter [84]. Previous 
DBS computational modeling studies have established that subject-specific 
inhomogeneous and anisotropic tissue property maps can significantly impact model 
predictions [85–87] and this effect is primarily attributed to the close proximity of DBS 
target brain structures to highly anisotropic axonal fiber tracts. Several methods have 
been proposed within the literature to model anisotropy, each relying on diffusion tensor 
imaging (DTI). 
DTI is a medical imaging technique based on MRI, which is used to map the diffusion of 
water molecules in tissue. The image contrast is generated by the diffusion of water 
molecules in response to the application of multiple magnetic field gradients. In 2001 
Tuch and colleagues demonstrated a linear relationship between the diffusion of water 
molecules and ion movement in the brain, which allows for the calculation of an 
anisotropic conductivity tensor from DTI [88]. Using this relationship, the matrix of 
conductivity tensor eigenvalues (Λσ) is calculated by scaling the diffusion tensor 
eigenvalues (λ1, λ 2, and λ 3) by a factor s: 
Λ𝜎 = 𝑠 ∗ [
𝜆1 0 0
0 𝜆2 0
0 0 𝜆3
]     (9) 
The anisotropic conductivity tensor (σ) is then calculated from its eigendecomposition 
using the matrix of DTI eigenvectors (V): 
𝜎 = 𝑉Λ𝜎𝑉
𝑇       (10) 
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In addition to the Tuch method for incorporating anisotropy, several other methods have 
been proposed within the literature, whereby the matrix of conductivity tensor 
eigenvalues is calculated differently. Examples include: (1) constraining the volume of 
each diffusion tensor and imposing a predefined anisotropy ratio [89] and (2) normalizing 
each diffusion tensor eigenvalue by the diffusion tensor volume and scaling the result by 
the isotropic conductance value for the appropriate tissue [90]. Each of these techniques 
generates personalized tissue property maps that are used to create personalized 
computational models that are inhomogeneous, anisotropic, and in the case of the two 
examples provided, allow for the inclusion of dispersion. To calculate the potential in 
tissue during electrical stimulation using these complex tissue property maps, simple 
electrostatic or time-domain FEA stimulations cannot be utilized. Rather, the analysis 
must be performed in the frequency domain following the technique described by Butson 
and McIntyre in 2005 for neurostimulation applications [91], termed the Fourier finite 
element method. 
1.3.3. Waveform modulation using the Fourier finite element method 
The Fourier finite element method (FFEM) allows for computation of a time-dependent 
stimulation waveform throughout the volume conductor model. For models of DBS, the 
FFEM involves first transforming the stimulation pulse into the frequency domain using 
the discrete Fourier transform (DFT). Next, FEA is performed in the frequency domain 
for stimulation at each of frequency bins contained within the DFT solution. To capture 
the dispersive effects in tissue, tissue properties may be assigned for each FEA frequency 
using the appropriate frequency-dependent values from the Gabriel dispersion equation. 
Next, at any coordinate within the finite element model, the complex voltage from the 
FEA solution is used to scale and shift the DFT result. Finally, the inverse DFT (iDFT) of 
the scaled and shifted spectrum is used to generate a time-dependent stimulation 
waveform that has been sculpted by the resistive, capacitive, and dispersive aspects of the 
tissue map.  
Using the FFEM in combination with personalized volume conductor models of the brain 
provides the ability to model small changes in the time-dependent stimulation waveforms 
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delivered using DBS. Ultimately, however, the effects of DBS are dependent on cellular 
responses to stimulation. Therefore, multi-compartment cell models are paired with 
volume conductor models to generate spatial activation profiles and activation profile 
curves. 
1.3.4. Modeling cellular activation 
Volume conductor models provide the means to estimate potential in brain tissue during 
stimulation; however, the ultimate goal is to understand the impact of electrical 
stimulation on neurons. Simple equivalent circuit models of axons are used for this 
purpose. For example, a length of axon membrane, or node, may be modeled using a 
capacitance (Cm) to represent the resting cell membrane, placed in parallel with a battery, 
representing the resting potential of the cell, and a resistance (Rm), representing the 
resistance of the membrane ion channels connected in series. A fiber can then be created 
by linking multiple nodes together using an axial resistance that represents the axon 
internal resistance. Simulating the response of this circuit to an applied electric field can 
be performed using circuit modeling software such as Simulink or the Neuron 
programming environment [92]. The cellular response to stimulation, firing of an action 
potential or not, is dependent on the transmembrane potential (Vm), which is the 
difference between the intracellular and extracellular (Ve) voltage minus the resting 
potential. An action potential occurs when the difference of the extracellular voltage 
across two nodes is large enough to cause a transmembrane potential that exceeds the 
threshold potential of the cell, which opens voltage gated sodium channels. Relying on 
these principles and using Kirchoff’s law, one can formulate the nonlinear cable equation 
for unmyelinated axons [73,93]: 
𝜆2
𝜕2𝑉𝑚
𝜕𝑥2
+ 𝜏𝑚
𝜕𝑉𝑚
𝜕𝑡
− 𝑉𝑚 = −𝜆
2 𝜕
2𝑉𝑒
𝜕𝑥2
     (11) 
where λ is the space constant: 
𝜆 =
1
2
√
𝑅𝑠𝑚𝑑
𝑅𝑎
      (12) 
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where Rsm is the specific membrane resistance, Ra is the axoplasmic-specific resistance, 
and d is the axon diameter. The axon time constant, τm, is given by:  
𝜏𝑚 = 𝑅𝑚𝐶𝑚      (13) 
Further, one can model the effect of an applied electric field on a myelinated axon using 
the discrete cable equation for myelinated axons [94,95]: 
𝑅𝑛
𝑅𝑎
Δ2𝑉𝑚 − 𝑅𝑛𝐶𝑛
𝜕𝑉𝑚
𝜕𝑡
− 𝑉𝑚 = −
𝑅𝑛
𝑅𝑑
Δ2𝑉𝑒    (14) 
where Rn is the membrane resistance at the node of Ranvier, Ra is the resistance between 
adjacent nodes, Cn and is the capacitance at the node of Ranvier: 
𝑅𝑛 =
𝑅𝑠𝑛
𝜋𝑑𝑙
      (15) 
𝑅𝑎 =
4𝑅𝑠𝑎𝐿
𝜋𝑑2
      (16) 
𝐶𝑛 = 𝐶𝑠𝑛𝜋𝑑𝑙     (17) 
where d is the unmyelinated fiber diameter, l is the node of Ranvier length, L is the 
distance between nodes, and the subscript s indicates specific resistance or capacitance of 
the membrane at the nodes. This set of equations differs from the unmyelinated cable 
equation in that is takes into account the presence of the myelin sheath, which causes 
action potential propagation to occur through salutatory conduction. For axon models 
within the central nervous system, such as those presented within this thesis, the anatomy 
generally mandates the use of the cable equation for myelinated axons.   
Modeling of cellular activity that was performed in the following sections of this thesis 
utilized populations of individual multi-compartment axon models are used to predict 
cellular activation. These models are based on the McIntyre et al. double-cable model of 
a generalized mammalian nerve fiber [96], which represents the axon as a repeating series 
of compartments representing different aspects of a myelinated axon, with a single 
compartment representing each node of Ranvier. Simulating the response of the double-
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cable model of a generalized mammalian nerve fiber is performed using Neuron 
programming environment [92] by applying an extracellular voltage to each compartment 
that is consistent with the voltage calculated from FEA volume conductor model solution 
during DBS. Quantifying the cellular responses from a population of model axons was 
performed by varying the stimulation amplitude in order to determine the minimum 
amplitude that results in the occurrence of an action potential for each model neuron 
within the population. Using the stimulation threshold for each axon, axons which are 
activated by stimulation at specific amplitudes are grouped to define a spatial activation 
profile or an activation profile curve. 
1.4.Objectives and research goals 
Despite high interest in personalized models of deep brain stimulation that combine 
highly complex volume conductor models with multi-compartment cell models, these 
models are underutilized for assessment of novel electrode technologies. Additionally, 
while these models provide the means to estimate cellular responses to electrical 
stimulation with a high degree of precision, the accuracy of these estimates are dependent 
on assumptions regarding tissue electric properties and the placement and biophysics of 
cellular models. The following chapters of this thesis describe computational modeling 
efforts to evaluate novel DBS electrode designs in the context of relevant anatomical 
models and seek to address the issue of model validation using behavioral and 
electrophysiological measures.  
Chapter 2 describes the development of a computational model to evaluate the utility of 
DBS arrays with increasing numbers of electrodes distributed around a DBS lead.  This 
study compared the ability of various lead designs to steer current using quantified 
measures. This study then evaluated the accuracy of several machine learning feature sets 
for predicting the optimal stimulation configuration using a four radial electrode deep 
brain stimulation array. Chapter 3 describes the development of a personalized 
computational model of deep brain stimulation using a preclinical animal model for 
computational model validation. In this study, model predictions using a range of 
personalized tissue property maps were evaluated using experimental data, which 
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included behavioral responses and electrophysiological recordings from motor cortex. 
Chapter 4 describes the development of a personalized model of endovascular DBS. This 
study used a personalized model to map out the neurovasculature of a single-subject and 
compare the effects of endovascular DBS to conventional DBS using two investigational 
brain targets.  
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2. DBS array design and machine learning feature sets 
This chapter reprinted with permission from Frontiers in Computational Neuroscience. 
 
Teplitzky BA, Zitella LM, Xiao Y and Johnson MD (2016) Model-Based 
Comparison of Deep Brain Stimulation Array Functionality with Varying Number of 
Radial Electrodes and Machine Learning Feature Sets. Front. Comput. Neurosci. 
10:58. doi: 10.3389/fncom.2016.00058 
2.1.Overview 
2.1.1. Objective 
Deep brain stimulation (DBS) leads with radially distributed electrodes have potential to 
improve clinical outcomes through more selective targeting of pathways and networks 
within the brain. However, increasing the number of electrodes on clinical DBS leads by 
replacing conventional cylindrical shell electrodes with radially distributed electrodes 
raises practical design and stimulation programming challenges.  
2.1.2. Approach 
Computational modeling was used to investigate: (1) how the number of radial electrodes 
impact the ability to steer, shift, and sculpt a region of neural activation (RoA), and (2) 
which RoA features are best used in combination with machine learning classifiers to 
predict programming settings to target a particular area near the lead. Stimulation 
configurations were modeled using 27 lead designs with one to nine radially distributed 
electrodes. The computational modeling framework consisted of a three-dimensional 
finite element tissue conductance model in combination with a multi-compartment 
biophysical axon model. For each lead design, two-dimensional threshold-dependent 
RoAs were calculated from the computational modeling results. 
2.1.3. Main results 
The models showed more radial electrodes enabled finer resolution RoA steering; 
however, stimulation amplitude, and therefore spatial extent of the RoA, was limited by 
charge injection and charge storage capacity constraints due to the small electrode surface 
area for leads with more than four radially distributed electrodes. RoA shifting resolution 
was improved by the addition of radial electrodes when using uniform multi-cathode 
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stimulation, but non-uniform multi-cathode stimulation produced equivalent or better 
resolution shifting without increasing the number of radial electrodes. Robust machine 
learning classification of 15 monopolar stimulation configurations was achieved using as 
few as three geometric features describing a RoA. 
2.1.4. Significance 
The results of this study indicate that, for a clinical-scale DBS lead, more than four radial 
electrodes minimally improved in the ability to steer, shift, and sculpt axonal activation 
around a DBS lead and a simple feature set consisting of the RoA center of mass and 
orientation enabled robust machine learning classification. These results provide 
important design constraints for future development of high-density DBS arrays. 
2.2. Background 
Deep brain stimulation is a neurosurgical intervention for symptomatic treatment of a 
number of brain disorders. The success of DBS therapy relies on accurate electrode 
placement within the brain [25] and generation of spatially defined tissue voltage 
distributions that can precisely modulate brain activity with millimeter, or even sub-
millimeter resolution [29]. The size of the anatomical targets, and their proximity to 
neural pathways that when stimulated generate unwanted side-effects, making selective 
modulation challenging for this therapy. Commercial DBS leads currently consist of a 
stack of cylindrical shell electrodes that can accommodate current steering along the lead 
axis [30–33]. Such current steering can be useful for enhancing the ability to target the 
subthalamic nucleus [67,85,97], globus pallidus [98,99], and motor thalamus [85,97,100]. 
However, the cylindrical electrode design of current DBS leads produces predominantly 
axisymmetric modulation of neuronal activity [100]. This axisymmetric modulation 
enables inadequate flexibility to adapt stimulation to compensate for neurosurgical 
targeting errors tangential to the DBS lead [100,101] or for targeting anatomical regions 
with complex geometries [87,102]. In such cases, delivering therapy without evoking side 
effects such as phantom sensory perceptions, involuntary motor contractions, and 
cognitive/mood changes can be challenging [31,67,100]. 
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The concept of current steering with implantable electrode arrays has existed in the fields 
of spinal cord stimulation [103,104], intracochlear stimulation [105,106], and retinal 
stimulation [107,108] for some time. Recent computational and experimental work has 
also applied this concept to preclinical and clinical DBS electrode arrays, which employ 
three to four radially distributed electrodes per row and several rows per lead [101,109–
113]. Such DBS arrays have potential to improve steering, shifting, and sculpting of 
neural activation beyond the capacity of conventional DBS leads with cylindrical shell 
electrodes. However, it is presently not clear how the number of radial DBSA electrodes 
impact the ability to steer, shift, and sculpt a region of neural activation. 
In addition to the challenges associated with understanding current steering with DBS 
arrays, leads with more than the conventional four electrodes have the potential to create 
significant patient programming challenges. Currently, clinicians select programing 
settings for a patient using trial-and-error through a monopolar review. A clinician will 
systematically stimulate through each of the available electrodes using increasing 
stimulation amplitudes, evaluate the patient's symptoms and the presence of side effects, 
and select the optimal stimulation configuration for the patient [34]. With only four 
electrodes this can be a time consuming and imprecise task. Increasing the number of 
electrodes has the potential to greatly complicate this problem, making programming 
impractical or even infeasible in a clinical setting. To address this issue, model based 
optimization algorithms [114] and machine learning classifiers [115] have been proposed. 
In general, the goal of these algorithms is to use medical imaging to determine the 
location of an implanted DBS lead relative to the targeted brain region and using this 
information, predict potentially therapeutic stimulation settings in order to guide the 
clinician in programming the implanted DBS system. Implementation of such techniques; 
however, relies heavily on the identification of robust quantifiable measures, or features, 
that describe the desired region or volume of activation. Currently, it remains unclear 
which RoA features are best used in combination with machine learning classifiers to 
predict programming settings to target a particular area near a DBSA. 
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In the first section of this manuscript we used computational modeling to explore DBSA 
lead design and current steering strategies. In particular, we calculated the maximum 
stimulation amplitude for various DBSA designs in the context of charge injection and 
charge storage capacity limits. We then investigated the size, shape, and location of a 
region of neural activation resulting from stimulation using a variety of electrode 
configurations within these limits. In the second section of this manuscript, we evaluate 
various machine learning feature sets for predicting stimulation settings to target a 
particular region near the DBS lead.  
2.3.Methods 
2.3.1.  Radially segmented DBS arrays 
Twenty-four deep brain stimulation array and three non-array leads were created in 
COMSOL Multiphysics v4.4. DBSA leads included two to nine electrodes per row. Each 
DBSA electrode was constructed by projecting an ellipse onto the cylindrical lead body 
and extruding the resulting surface 0.1 mm into the lead body. The width of the projected 
ellipse (Figure 1) was calculated using the equation of a chord whose endpoints lie on a 
circle with a diameter equal to the lead body diameter, 1.27 mm (Equations 18, 19). 
𝛩 =
360
𝑛
     (18) 
𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑑𝑒 𝑤𝑖𝑑𝑡ℎ = 𝑑 ∗ sin (
𝛩
2
)    (19) 
where Θ was the center-to-center electrode separation, d was the lead body diameter, and 
n was the number of radial electrodes in a row. Non-array leads included conventional 
cylindrical shell electrodes. Both array and non-array electrodes were constructed with 
three heights: 0.5, 1.0, and 1.5 mm. Each DBS lead included four rows of electrodes and 
the separation between rows was equal to electrode height. Each lead diameter was 1.27 
mm in accordance with the diameter of the clinical Medtronic 3387 and 3389 DBS leads 
(Medtronic Inc., Minneapolis, MN). To simplify reference to each DBS lead design, the 
following naming convention was implemented: DBSA–e[number of radial electrodes]–
h[electrode height]. For example, DBSA–e4–h1.5 would refer to the DBSA lead with 4 
radial electrodes per row, each with a height of 1.5 mm. 
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Figure 1. DBSA lead design. DBSA leads were designed with two to nine electrodes per 
row. DBSA electrode width and radial separation were calculated for each lead design 
using Equations (18, 19). The DBSA–e3–h1.5 lead design is shown. Electrode height was 
1.5 (shown), 1.0, or 0.5 mm. Tissue conductance models 
Simulations were conducted using only the bottom row of electrodes for each lead. A 
three-dimensional tissue conductance model was created for each stimulation 
configuration using Comsol Multiphysics v4.4 and solved for using the finite element 
method (FEM; Figure 2A). Each tissue model incorporated a lead body (σ = 1e−12 S/m), 
electrodes (σ = 1e6 S/m), a 0.25 mm thick encapsulation layer (σ = 0.18 S/m [116,117]), 
and a 20 cm diameter sphere representing bulk neural tissue (σ = 0.3 S/m [79,80]). Point 
current-sources were placed at the three-dimensional center of each electrode. The 
surface of the bulk neural tissue sphere was set to ground, i.e., zero volts, via Dirichlet 
boundary conditions. A variable resolution mesh containing quadratic tetrahedral 
elements ranging from 0.2 mm near the electrode to 10 mm near the model perimeter was 
generated via Delaunay triangulation. The resulting mesh contained 280,000–310,000 
elements depending on the lead design. To confirm that further mesh refinement was not 
advantageous, the average relative change in the calculated potentials were determined at 
the midpoint of each axon model compartment using a mesh with elements that were two 
and three times smaller than the previously described model. The average relative change 
in the calculated potentials was found to be < 1% for these more refined models.  
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Figure 2. Modeling axonal activation. Tissue voltage during stimulation was modeled for 
each stimulation configuration using the finite element method (A). The multi-
compartment axon model population superimposed with extracellular potentials derived 
from the tissue voltage predictions (B). A spatial axonal activation profile, or region of 
activation (RoA) plot resulting from stimulation at 2.5 mA (C). RoA quantification using 
regional properties calculated from a closed binary image of the RoA plot (D). 
To investigate impact of the changes to the electrode-tissue interface (ETI) resulting from 
novel electrode geometries, a three-element Randles equivalent circuit model of the ETI 
was constructed for the lead with the smallest and largest electrode surface areas. In these 
models, the Fourier FEM described by Butson and McIntyre [91] was implemented so 
that capacitive effects of the ETI could be captured. Briefly, the Fourier FEM was carried 
out by creating a waveform with a 90 μs cathodic pulse in the time domain (dt = 1 μs), 
performing the 1024 point discrete Fourier transform (DFT), solving the finite element 
model (εr=1×10
6
 [83]) at each of the 513 frequencies represented within the DFT (0–512 
kHz), scaling and phase shifting the finite element model results by the DFT magnitude 
and phase, and finally performing the 1024 point inverse DFT on the result to reconstruct 
the stimulation waveform in the time domain. The equivalent circuit model was 
represented at the electrode surface within the frequency dependent finite element model 
as a circuit terminal using the Comsol Multiphysics AC/DC module. In accordance with 
previous work [118], the equivalent circuit model included an access resistance, Ra, in 
series with a parallel RC pair consisting of a faradaic resistance, Rf, and double layer 
capacitance, Cdl. Ra was calculated using the finite element model solution for 1 volt 
applied at the electrode surface from which the effective applied current was calculated 
by integrating the normal current density across the electrode surface and taking the 
reciprocal. Rf and Cdl were calculated from the distributed faradaic resistance (150 Ω-
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cm
2
 [119]) and the distributed double layer capacitance (30 μF/cm2 [119]) using the 
electrode surface area. Inclusion of the ETI was confirmed to have no discernable impact 
on the stimulation results, and thus the ETI equivalent circuit model was excluded from 
subsequent simulations. 
2.3.3. Stimulation configurations 
Current-regulated stimulation was modeled using one or multiple independent sources. 
Variations on stimulation configuration were constrained to monopolar settings and 
included single-cathode stimulation, uniform multi-cathode stimulation, and non-uniform 
multi-cathode stimulation. Uniform multi-cathode stimulation involved uniformly 
splitting the total cathodic current across all designated cathodes. Non-uniform multi-
cathode stimulation involved assigning different proportions of total cathodic current to a 
single, primary cathode, and evenly distributing the remaining cathodic current across the 
remaining electrodes in a given row. Simulations of 15 monopolar single-cathode and 
uniform multi-cathode stimulation configurations using only the DBSA–e4–h1.5 lead 
were used for machine learning feature set analysis. 
2.3.4.  Multi-compartment axon models 
Three-dimensional multi-compartment myelinated axon models were distributed within a 
lead-centered 13-by-13 mm grid. Axons were separated by 0.25 mm and aligned parallel 
to the DBS lead. While the axon model orientations were generated in an artificial 
framework, the orientations were generally similar to fiber tracts (e.g., corticospinal tract 
of internal capsule) [115] that course approximately parallel to clinical DBS lead targets 
(e.g., subthalamic nucleus DBS) and that are hypothesized to elicit side effects when 
stimulated [120]. Fibers were modeled with a 2 μm diameter [121] and populated with 
compartments representing nodes of Ranvier, myelin attachment segments, paranode 
main segments, and internode segments connected through an axial resistance. Axon 
compartment properties were consistent with the multi-compartment cable model axon 
developed and described in detail by McIntyre et al. [122]. 
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Rather than incorporating tissue conductance using the computationally expensive 
Fourier FEM method, the quasistatic solution at each axon compartment was scaled by a 
time-varying experimentally-recorded 135 Hz charge-balanced current-regulated 
stimulation waveform [123] (Equation 20).  
Φ(𝑥, 𝑦, 𝑧, 𝑡) = Φ(𝑥, 𝑦, 𝑧) ∗ 𝑤(𝑡)     (20) 
Extracellular potential, represented by Φ for a given model axon compartment was scaled 
by the time varying 135 Hz waveform, w(t). The charge-balanced waveform consisted of 
a 90 μs pulse followed by a 400 μs interphase delay and a 3 ms pulse with opposite 
polarity. The waveform-scaled extracellular potential was dynamically incorporated into 
the model axon compartments (Figure 2B) using the Neuron programming environment 
v7.3 [124]. Within the Neuron programming environment, the axonal membranes were 
perturbed by driving membrane current using the extracellular mechanism 
(e_extracellular), with parameters consistent with previous work [102].  
2.3.5.  Calculating neural activation thresholds and regions of activation  
The total applied cathodic current threshold for inducing axonal spiking was calculated 
for each model axon within each tissue voltage model using a binary threshold-searching 
algorithm. The algorithm relied upon trial-and-error within a narrowing range of 
stimulation amplitudes that was considered to have converged once the range of 
stimulation amplitudes was reduced to 0.01 mA. Axons were considered “activated” if an 
action potential was recorded within 3 ms of stimulation following 8 out of 10 
stimulation pulses at the distal node of Ranvier. For each stimulation configuration, two-
dimensional spatial activation plots, referred to as region of activation (RoA) plots, were 
generated by plotting the cross-section of the axon population with activation-thresholds 
less than or equal to a specified stimulation amplitude (Figure 2C). Where charge storage 
capacity and charge injection limits were considered, the maximum safe stimulation 
amplitude was calculated using Equations 21 and 22, respectively. The reversible charge 
storage capacity, 150 μC/cm2, represented the upper limit of reported values [125,126] 
for platinum-iridium electrodes like those generally used in DBS for cathodic-pulse 
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leading charge balanced waveforms. The charge injection limit was characterized by a 
safety factor, k = 2.0, was derived from the charge per phase verses charge density per 
phase relationship [125,127] as a limit for safe charge delivery to neural tissue.  
𝐼𝐶𝑆𝐶 =  
𝐶𝑆𝐶 × 𝐴
𝑝𝑤
     (21) 
𝐼𝑆𝐹 =  
√𝐴 × 10𝑘
𝑝𝑤
     (22) 
With stimulation amplitude in amperes, I; charge storage capacity in μC/cm2, CSC; 
surface area of a single electrode in cm
2
, A; and cathodic pulse-width, pw.  
2.3.6.  RoA quantification 
Binary image analysis techniques were used to extract quantifiable metrics from each 
RoA at amplitudes ranging from 1 to 5 mA in 0.1 mA increments resulting in 41 RoAs 
per stimulation configuration. These techniques were used for quantification rather than 
precise measurement of the spatial activation profile to ensure that the process could be 
replicated in the context of post-operative medical imaging for the purpose of patient 
programing. Post-processing began with saving RoA plots spanning the 13-by-13 mm 
axon-space within 20-by-20 cm lead-centered images. A binary transform of each image 
was performed and morphologically closed using disk-shaped elements in order to 
preserve the ellipsoidal nature of the region. Regional properties including area, 
perimeter, center-of-mass (CoM), major axis length, and minor axis length were extracted 
from each of the closed images (Figure 2). 
From these regional properties, several metrics were calculated to compare lead designs. 
These included lateral shift, angular shift, aspect ratio, target region coverage, and target 
region overspill. Lateral shift was calculated as distance from the lead-center to the RoA 
CoM in the direction of the primary cathode (usually along the x-axis). Angular shift, in 
the context of single-cathode stimulation through two neighboring electrodes, was 
calculated as the angle, in degrees, between vectors running from the lead-center to each 
RoA CoM. Aspect ratio was calculated as the RoA minor axis length divided by the RoA 
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major axis length. Target region coverage and overspill were calculated for a set of 
experiments where a target region was placed between neighboring electrodes. These 
experiments were run using only the DBSA–e4–h1.5, which has electrodes separated by 
90°. The target region, therefore, was generated from the same lead but was rotated 45° 
about the lead-center. Overlap between the target region and the activated region was 
calculated by first multiplying the binary image transforms of the two regions and then 
calculating the percent of the target region area covered by the overlapped region. 
Overspill was estimated by multiplying the binary image transforms of the activated 
region and the inverse of the target region, and then calculating the resulting area in 
mm2. Overlap and overspill were calculated for stimulation amplitudes ranging from 1 to 
5 mA at 0.1 mA increments using three monopolar configurations. All processing and 
calculations of regional properties were performed using the Matlab Image Processing 
Toolbox (v2014b). 
2.3.7.  Feature sets 
Feature sets (Table 2) were derived from simulations of 15 monopolar stimulation 
configurations using the DBSA–e4–h1.5 lead (Figure 3). Because RoA measures were 
conducted at 41 amplitudes (1 to 5 mA in 0.1 mA increments) using 15 stimulation 
configurations, feature sets for 41 × 15 = 615 RoAs were generated. Post-processing of 
RoA plots was performed using the same binary image analysis techniques as described 
in Section 2.3.6. From the post-processed binary images, three feature sets were 
generated: a region properties feature set (RPFS), a Legendre polynomial feature set 
(LPFS) [128], and a 7 Hu invariant moments feature set (7 HuIM) [129]. The RPFS 
included the common region properties; center or mass, area, perimeter, convex hull area, 
solidity as well as features derived from an ellipse fit to the RoA; eccentricity, 
orientation, major axis length, and minor axis length. The LPFS was generated using the 
distance transform of each RoA binary image. The distance transform results were sorted 
in ascending order, normalized to the largest value, and fit to a 9th order Legendre 
polynomial. The features consisted of the coefficients of this 9th order Legendre 
polynomial. The majority of features that were investigated originate from computer 
vision applications where desirable traits include invariance to scale, rotation, and 
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translation [130]. We hypothesized that the ideal feature set for prediction of stimulation 
configuration would (1) be rotation and translation variant since RoA direction underlies 
current steering, and (2) scale invariant with regard to stimulation amplitude but not with 
regard to RoA offset. To achieve this, distance of the RoA CoM from lead-center in the x 
and y directions were included in each feature set. 
Table 2. Features extracted from simulations using the DBSA-e4-h1.5 lead.
Number Feature 
1 Center of mass x-coordinate  
2 Center of mass y-coordinate  
3 Eccentricity of ellipse fit 
4 Orientation of ellipse fit 
5 Major axis length of ellipse fit 
6 Minor axis length of ellipse fit 
7 Area  
8 Perimeter  
9 Convex hull area  
10 Solidity 
11-20 Legendre polynomial coefficients from distance transform [128] 
20-27 7 Hu invariant moments [129] 
Twenty-seven features were extracted from each RoA. The region properties feature set 
(RPFS) included features 1 through 10. The Legrendre polynomial feature set (LPFS) 
included features 1, 2, and 11 through 20. The 7-Hu invariant moments feature set 
(7HuIM) included features 1, 2, and 20 through 27. 
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Figure 3. Machine learning feature set generation. Machine learning features were 
extracted from simulation results spanning 15 monopolar stimulation configurations at 
simulation amplitudes ranging from 1 to 5 mA in 0.1 mA increments. 
2.3.8. Classification and feature set quality assessment 
Each of the 615 samples in the proposed classification problem included all features 
(Table 2) from a single RoA. The goal of the classification problem was to classify each 
sample, using a subset of features i.e., one of the three feature sets, as originating from 
the correct stimulation configuration, of which there were 15. The quality of each feature 
set was assessed using 10-fold cross validation of five classification models: k-nearest 
neighbor (KNN), naïve Bayes (NB), a multi-class support vector machine (mSVM) with 
a radial-basis function kernel [131], a two-layer feed-forward pattern recognition neural 
network (NN) with 20 hidden elements, and a random forest (RF) decision tree ensemble 
with 100 trees [132]. All models except the mSVM were implemented using the Matlab 
Statistics Toolbox (v2014b). Training and testing data sets were pseudo-randomly 
divided within each cross validation fold such that each class was represented 
approximately equally and no samples were used for both training and testing. 
Classification accuracy was calculated for each fold as the number of correctly classified 
samples divided by the number of classified samples. The mean accuracy and standard 
error of the accuracy were then calculated across all 10 folds. 
Feature importance was assessed using sequential forward selection and Breiman's 
random forest algorithm. Sequential forward selection was performed using the neural 
network and naïve Bayes classifiers. In each case, starting with an empty feature set, the 
classifier was run using each of the 27 features and the feature with the highest accuracy 
was considered the most important and added to the feature set. Classification was then 
performed using each of the remaining 26 features in combination with the first elected 
feature, and again the feature with the highest accuracy was considered the most 
important and added to the feature set. This process was repeated until the feature set 
contained 10 of the 27 features. From the random forest classifier, feature importance 
was assessed by calculating the increase in prediction error that resulted from random 
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permutation of each feature across the out-of-bag samples. Features with the greatest 
effect on error were considered the most important. 
2.4. Results 
2.4.1.  Stimulation amplitude limits 
Increasing the number of radial electrodes resulted in a reduced electrode surface area. 
This in-turn lowered the theoretical stimulation amplitude that could be safely delivered 
through each electrode to neural tissue. More precisely, as the number of radial electrodes 
was increased both charge storage capacity and charge injection constraints limited the 
safe stimulation amplitude. This relationship followed an exponentially decaying trend 
(Figure 4). Charge injection constraints limited stimulation amplitude for leads with five 
or fewer radial electrodes with an electrode height of 1.5 mm. Charge storage capacity 
limited the stimulation amplitude for leads with more than five radial electrodes and 
electrode height of 1.5 mm. As electrode height was decreased, the intersection of the 
two lines: charge storage capacity constrained amplitude and charge injection constrained 
amplitude was shifted left, toward a smaller number of radial electrodes. Charge storage 
capacity was found to be the limiting factor for all DBSAs with an electrode height of 0.5 
mm. In accordance with the inclusion of surface area in Equations 21 and 22, stimulation 
amplitude limited by charge storage capacity was proportional to the electrode height, 
while stimulation amplitude limited by charge injection was proportional to the square 
root of electrode height. Most electrode designs (23/27) were limited to stimulation 
amplitudes below 10 mA per electrode, while approximately half (13/27) were limited to 
amplitudes below 5 mA using the 150 μC/cm2 and k = 2.0 limits. All DBSA designs with 
an electrode height of 0.5 mm were limited to amplitudes below 5 mA per electrode.  
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Figure 4. Stimulation amplitude limits. Maximum stimulation amplitude (for a biphasic 
waveform with a 90 μs initial pulse) was calculated for each lead design using a charge 
storage capacity of 150 μC/cm2 and a safety factor limit of k = 2.0 (A). RoAs resulting 
from stimulation amplitude limits for several example DBSA lead designs (B). 
2.4.2.  Steering, shifting and sculpting activation with single-cathode monopolar DBS 
Lateral shift, angular shift, and aspect ratio were used to evaluate the ability of each lead 
to shift, steer, and sculpt a RoA using monopolar stimulation within the range of 1–5 mA. 
Lateral shift for cylindrical shell electrodes did not significantly vary from zero as they 
produced a radially symmetric RoA. For all DBSA lead designs, at 1 mA, lateral shift 
increased from 0 mm to ~1.1 mm, regardless of the number of radial electrodes (Figure 
1) or electrode height. Lateral shift increased moderately from 1.1 mm to 1.3 mm with 
stimulation amplitude increasing beyond 1 mA for all DBSA lead designs. Aspect ratio 
increased with stimulation amplitude at a similar rate for DBSA lead designs with the 
same electrode height (Figure 5). Electrodes with shorter heights were found to produce a 
slightly more circular RoA resulting in an aspect ratio closer to 1. For instance, the mean 
aspect ratio at 1 and 5 mA increased from 0.48 and 0.63 for DBSAs with 1.5 mm 
electrodes to 0.51 and 0.65 for DBSAs with 0.5 mm electrodes. 
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Figure 5. Monopolar single-cathode lateral shift and aspect ratio. RoA lateral shift and 
aspect ratio for monopolar single-cathode stimulation using DBSA lead designs with 1.5 
mm electrode height within the range of 1–5 mA. Similar RoAs were produced from all 
DBSA designs (A). As stimulation amplitude was increased, lateral shift and aspect ratio 
both increased at similar rates (B,C). 
Angular shift varied in accordance with angular separation of electrodes (Figure 6). For 
example, the six radial electrode lead incorporated electrodes separated by 60° and the 
RoA CoM angular shift resulting from stimulation through neighboring contacts was 
calculated to be 60°. Angular shift did not vary for leads with different electrode height 
nor did it vary with stimulation amplitude. 
 
Figure 6. Monopolar single-cathode steering. Angular shift for monopolar single-cathode 
stimulation using DBSA lead designs with 1.5 mm electrode height within the range of 1 
to 5 mA. DBSA leads with more electrodes were capable of finer RoA CoM angular 
shifting (A) in accordance with electrode angular separation (B). 
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None of the stimulation configurations tested resulted in complete coverage of a rotated 
target region without moderate to large overspill (Figure 7). The dual cathode 
configuration performed the best overall. The angular shift for this configuration was 
closest to 45° and target coverage was highest with the lowest spillover. 
 
Figure 7. Steering toward an offset target region. Steering activation toward a target 
region between electrodes was investigated using DBSA–e4–h1.5 with single-cathode 
and multi-cathode stimulation configurations (A). The multi-cathode configuration 
performed best with a 45° angular shift (B) and exhibited the largest overlap and smallest 
overspill for any given stimulation amplitude (C). 
2.4.3.  Shifting and sculpting activation with multi-cathode monopolar DBS 
For each DBSA lead design, uniform multi-cathode stimulation using a larger proportion 
of available radial electrodes enabled shifting of the RoA CoM from 0, lead-center, to 
~1.3 mm in the direction of the primary cathode. The resolution with which RoA CoM 
could be shifted from one extreme to the other increased as the number of radial 
electrodes increased (Figure 8). Lateral shift increased slightly for larger stimulation 
amplitudes and did not change with electrode height. Increasing the proportion of active 
electrodes first decreased then increased aspect ratio for leads with more than four radial 
electrodes. The initial decrease in aspect ratio was a result of added cathodes facing the 
same direction as the center-most cathode. In general, increasing the proportion of active 
electrodes increased the aspect ratio toward one, indicating a more radially uniform RoA. 
These trends were found to be consistent for DBSA lead designs with different electrode 
heights.  
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Figure 8. Incremental CoM shifting using monopolar multi-cathode stimulation. 
Monopolar stimulation currents were uniformly split across an increasing number of 
radial electrodes for each DBSA (A). DBSAs with more radial electrodes enabled 
shifting within the same range but at improved resolution (B). Aspect ratio decreased 
initially for DBSAs with more than 4-radial electrodes and increased from ~0.5 to 1 as 
the proportion of active electrodes increased (C). 
Non-uniform multi-cathode stimulation enabled RoA CoM shifting within the same range 
as uniform current shifting, but with improvement in shifting resolution (Figure 8). 
Shifting resolution approximately doubled non-uniform multi-cathode stimulation using 
DBSA–e4–h1.5 in comparison to uniform multi-cathode stimulation using DBSA–e8–
h1.5. The aspect ratio range was approximately the same for uniform and non-uniform 
multi-cathode stimulation; however, the aspect ratio profile shifted to the left indicating 
that the non-uniform multi-cathode stimulation produced more circular RoAs (Figure 9). 
 
Figure 9. Multi-cathode, non-uniform current shifting of the CoM. Monopolar 
stimulation currents uniformly split across an increasing number of radial electrodes 
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using DBSA–e8–h1.5 compared to monopolar stimulation non-uniformly split across 
electrodes using DBSA–e4–h1.5 (A). Non-uniform configurations using DBSA–e4–h1.5 
resulted in improved shifting resolution in comparison to uniform configurations using 
DBSA–e8–h1.5 (B). Aspect ratio profile was similar for the two strategies but was 
shifted for non-uniform current shifting indicating more circular RoAs were generated 
from non-uniform shifting (C). 
2.4.4.  Classification 
Cross validation using 10 folds was performed using three feature sets in combination 
with five machine learning algorithms. In general, high mean classification accuracy was 
achieved with low standard error across the 10 folds. The random forest classification 
algorithm, which involves automated feature selection, performed best, achieving perfect 
classification using any of the three feature sets (Figure 10). Of the remaining classifiers 
where no feature selection/reduction was performed: the neural network classifier 
achieved perfect accuracy and the naïve Bayes classifier achieved accuracy above 0.95 
using the RPFS. Classification using the RPFS produced the highest accuracy for all 
except in the case of the k-nearest neighbors classifier. The LPFS and 7 HuIM feature set 
achieved similar accuracy when used in combination with the neural network, naïve 
Bayes and k-Nearest neighbors classifiers.   
 
Figure 10. Classification accuracy. Mean classification accuracy and accuracy standard 
error (represented by error bars) were calculated for each classifier/feature set 
combination across 10-folds. Perfect classification of monopolar stimulation settings was 
achieved with the random forest classifier using any of the three feature sets. The neural 
network, naïve Bayes and random forest classifiers achieved perfect or near perfect 
accuracy using the region properties feature set. 
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2.4.5.  Feature importance 
Sequential forward selection and results from the random forest classification algorithm 
were used to evaluate feature importance. Mean accuracy was calculated as an indicator 
of feature importance at each stage of the forward selection for both the neural network 
and naïve Bayes classifiers. From the random forest algorithm, mean effect on prediction 
error resulting from random permutation of each feature across the out-of-bag samples 
was used as an indicator of feature importance. A low standard error was calculated for 
all indicators of feature importance. Using either the neural network or naïve Bayes 
classifier, mean accuracy converged to one after the addition of the same four features: 
CoM x-coordinate, CoM y-coordinate, ellipse fit eccentricity and ellipse fit orientation. 
These same four features were ranked as the most important by the random forest 
algorithm (Figure 11). Although all features were included in the analysis, forward 
selection using the neural network and naïve Bayes classifiers resulted in the most 
important features being from only the RPFS.   
 
Figure 11. Feature importance. Sequential forward selection accuracy converged to one 
after the addition of features 1, 2, and 4 using both the neural network and naïve Bayes 
classifiers. From the random forest algorithm, the effect on classification error was 
increased most by the random permutation of features 1, 2, 3, and 4. Features 1: CoM x-
coordinate, 2: CoM y-coordinate, and 4: ellipse fit orientation were found to be the most 
important features and using only these three features in combination with the neural 
network and naïve Bayes classifiers enabled perfect classification. 
2.5. Discussion 
While DBS therapy is often successful in managing the symptoms of a range of 
medication-refractory brain disorders, the spatial precision with which the therapy can be 
delivered using a conventional lead with cylindrical shell electrodes can be limiting for 
cases of slight neurosurgical targeting error or for brain regions with complex 
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morphologies. Previous studies have developed methodologies to steer and direct 
activation volumes along a DBS lead studies [30–33,85], but less is known about 
programming stimulation settings around a DBS lead [101]. The results of this study 
show for a DBS lead embedded within or near a fiber tract that: (1) four ellipsoidal 
electrodes around a DBS lead provided good flexibility to steer, sculpt, and shift a region 
of neural activation without exceeding the charge storage capacity of platinum-iridium 
electrodes or charge injection limits for neural tissue, and (2) a small feature set, 
including only three geometric features representing a target region enabled robust 
machine learning classification of electrode stimulation configuration. 
2.5.1.  DBS array design considerations 
Microfabrication processes enable new opportunities to develop stimulating probe 
technology with many more electrode sites than what is currently in clinical use for DBS 
applications [101,133,134]. Increasing the number of electrodes and in turn decreasing 
the size of electrodes has several important effects on the region of neural tissue 
including limiting the spatial extent of the RoA due to charge storage capacity and charge 
injection limits [30,125]. Previous preclinical studies in animal models of neurological 
disorders have also noted that DBS therapy is partially based on modulating the neuronal 
firing patterns of a fairly large volume of tissue [98,99] within a target volume [29]. 
Thus, while increasing the number of electrodes may provide more spatially focused 
stimulation, generating a therapeutic effect through DBS arrays is likely to require 
grouping electrodes together for high-density DBS arrays. This grouping approach would 
be complicated by radial diffusion properties that result in higher charge densities near 
the edges of each electrode in a group [30,118]. 
In this study, we extend these results showing that charge storage capacity and charge 
injection are limiting factors, though to different extents as the number of radially 
electrodes is increased. For DBSA designs with small electrode surface areas, advanced 
electrode coatings [126,135,136] may address the issue of charge storage capacity, but 
the charge injection limits will remain an issue as was shown for DBSA lead designs with 
five or more radial electrodes. Elliptical electrodes with height ranging from 0.5 to 1.5 
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mm and width ranging from 0.2 to 0.9 mm were used in this study. For electrodes with 
the largest height and the smallest width, it is possible that these highly eccentric 
electrodes would have higher charge density values at the ends of the electrode major 
axis [137] similar to how large current density values are found at the corners of 
rectangular electrodes [30]. 
2.5.2.  Shaping the region of activation 
One of the primary motivations for advances in DBS lead and stimulator designs is to 
enable compensation for sub-optimally placed leads. Ideally, leads with cylindrical shell 
electrodes are implanted with one of the electrodes at the geometric center of the neural 
target enabling good stimulation coverage with minimal overspill. With targets that are 
several centimeters deep and only millimeters across, precise lead placement can be 
challenging. With a cylindrical shell electrode, a small offset in the final lead location 
may significantly limit stimulation efficacy and result in stimulation induced side effects 
resulting from activation of nearby pathways. DBSAs have been proposed as able to 
compensate for such placement issues [101,110,112]. As we have shown, monopolar 
stimulation through a single radial electrode resulted in a 1–1.3 mm RoA CoM lateral 
shift and increasing stimulation amplitude minimally affected the CoM location. 
Additional radial electrodes or proportional current steering provided options to 
incrementally shift the RoA CoM with sub-millimeter resolution, but in cases where 
more than a 1 mm shift in the RoA CoM is needed for compensation of lead 
misplacement, this need would not be adequately addressed by any of the DBSA designs 
evaluated in this study. The results showed that uniform multi-cathode stimulation 
enabled incremental CoM shifting, but was limited by the number of available radial 
electrodes. Non-uniform multi-cathode stimulation resulted in better shifting resolution 
with four radial electrodes than could be achieved using uniform multi-cathode 
stimulation with eight radial electrodes. From this we conclude that fewer electrodes does 
not limit shifting if non-uniform stimulation strategies are used. However, practical 
implementation of non-uniform stimulation requires fine and independent control of 
multiple stimulation channels. In regard to lead design, leads with fewer radial electrodes 
may be preferable because of larger electrode surface areas and possibly less complex 
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manufacturing processes. In regard to implantable pulse generator design, fewer 
independent current sources may be preferable to allow for device miniaturization. 
Stimulators with independent current-regulated channels are well-established in the fields 
of spinal cord stimulation for pain mediation [138], auditory nerve stimulation for 
hearing restoration [139], and retinal stimulation for vision restoration [107]. The advent 
of stimulators with independent channels in these fields have prompted significant 
research into the utility of various stimulation strategies for directing and focusing 
current, particularly in the case of auditory nerve stimulation, where highly conductive 
fluid separates the stimulating electrodes from the stimulation target [140]. Strategies for 
steering and focusing stimulation include the use of multiple sources to steer a region of 
neural activation and the use of bipolar stimulation to narrowly focus current [106,141]. 
These strategies have been implemented with varying degrees of success for cochlear 
implants and spinal cord stimulation. These strategies have also been investigated in DBS 
systems via modeling studies [31,85] and clinical studies [32,33] for the purpose of 
steering neural activation along the length of a conventional DBS lead. Our results 
indicate that for steering, shifting, and sculpting of neural activation around the lead, a 
DBSA with four electrodes per row combined with a pulse generator that has 
independent current sources for each electrode would be highly effective at steering and 
shifting a region of neural activation around a DBSA lead. Our results also indicate that 
more than four electrodes would be minimally advantageous. 
Radial shifting and steering have potential to benefit clinical outcomes for a number of 
DBS targets [142]. For instance, the subthalamic nucleus target for Parkinson's disease is 
adjacent to the corticospinal tract of internal capsule [31] and non-motor territories of the 
subthalamic nucleus [67] that when stimulated can lead to adverse side effects. The 
ventral intermediate nucleus of thalamus, which is the primary target for treating 
Essential Tremor, is adjacent to the internal capsule, the somatosensory nucleus of 
thalamus, and non-motor pathways involved in language and cognition [143]. Similarly, 
the pedunculopontine tegmental area is replete with adjacent fibers of passage including 
the superior cerebellar peduncle, medial and lateral lemnisci, and the central tegmental 
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tract among others that may have confounding effects on treatment of medication-
refractory gait disorders [87]. Radial current shifting and steering may also have 
important applications to DBS targets that are embedded within fiber tracts including 
those for depression [144], obsessive compulsive disorder [145], and memory disorders 
[12]. 
2.5.3.  Machine learning to facilitate programming 
Along with greater flexibility in directing neural activation, DBS arrays present 
exponentially more options during programming. This necessitates the use of (1) guided 
programming through computational algorithms [114,115], and (2) empirical algorithms 
that rely on the spatial distribution of electrophysiological biomarkers [146]. Here, we 
investigated feature sets to be used in building machine learning classifiers for predicting 
DBSA stimulation settings. These feature sets were constructed from the two-
dimensional computational modeling results of axonal activation using the DBSA–e4–
h1.5 lead and relied upon computer vision feature extraction techniques. In computer 
vision, feature extraction is commonly performed to identify objects that may be 
“viewed” by a machine using images or video that was captured and processed internally. 
Robust computer vision identification requires that objects be identifiable when viewed at 
different distances, angles, and locations within the field of view requiring the use of 
scale, rotation, and translation invariant feature sets [130]. The feature sets we have 
designed for use in machine learning classifiers for DBS rely on these same principles, 
but include a center of mass estimate that is relative to the lead-center so that changes in 
the RoA direction and shift may be detected. In addition to investigating the value of 
various features for such classification algorithms, we have demonstrated robust machine 
learning classification of electrode stimulation configuration using a single row of 
electrodes. Our investigation into feature sets revealed that excellent classification could 
be achieved using a small number of two dimensional geometric features that may be 
readily translated in three-dimensional geometric measures. Running axon model 
simulations, feature extraction, and classifier training required significant computation 
time, but the resulting five classification algorithms were able to be deployed in less than 
1 min using a conventional desktop computer. The speed with which such algorithms can 
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be deployed demonstrates the power and practicality of such algorithms for use in clinical 
DBS programming. 
2.5.4.  Limitations 
The quasistatic finite element models used for predicting tissue voltage in this study were 
idealized as isotropic and were homogeneous within bulk neural tissue. Increasingly 
complex models that more precisely model tissue conductivity using diffusion weighted 
imaging have been introduced in the past decade and have been shown to impact 
biophysical simulation results [29,147,148], particularly for modeling of electrical 
stimulation near white matter fiber tracts [29,149]. Further, the conductance values 
utilized in the tissue models presented here rely on experimentally determined values for 
conductance that are subject to uncertainty as evident by the range of values reported 
within the scientific literature [82,150]. Variations of tissue conductance within the range 
of reported values have been shown to lead to significant uncertainty in the activation 
predictions of biophysical models [151]. Additionally, stimulus waveforms propagating 
through encapsulation and brain tissue are likely to be influenced reactive tissue 
impedances [152–155] and the quasistatic model does not incorporate this feature. Using 
the modeling framework presented here, future work may assess the impact of variations 
in conductance, brain anisotropy, and reactive tissue response on the DBSA design and 
feature selection for model based programing algorithms. 
The multi-compartment axon models used in this study were idealized straight cables 
coursing parallel to the DBS lead. Modeling work with straight axons has potential utility 
for DBS targets that are within or near large fiber tracts that have minimal curvature 
[12,144,145,156]. However, it is important to consider that this idealized model geometry 
lacks the anatomical trajectories known to occur in many targets of DBS. In these cases, 
factors such as stimulating regions with networks of cellular and axonal processes [87], 
inducing complex cellular entrainment patterns [7,157], and increasing the likelihood of 
axonal conduction failure due to axonal branching [158], lack of myelination [159], and 
synaptic fatigue [160] should be considered. 
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Elimination of the ETI from the finite element models relied on a subset of simulations 
that incorporated an ETI equivalent circuit model that assumed the electrode material was 
platinum-iridium. To avoid exceeding the charge storage capacity of the electrodes with a 
clinically acceptable factor of safety, realistic lead designs with small electrodes would 
likely require the use of coatings such as iridium oxide [126], PEDOT [161], or TiN 
[162] for which lumped ETI equivalent circuit model values would likely differ.  
2.6. Conclusions 
DBS arrays with radially distributed electrodes have potential to improve patient 
outcomes by enhancing the flexibility of directing stimulation around an implanted DBS 
lead. Clinical DBS leads with cylindrical shell electrodes do not exceed electrode charge 
storage capacity or charge injection limits due to the large surface area and existing 
voltage or current compliances of current implantable pulse generators. However, 
segmenting the cylindrical shell electrode design into two or more electrodes around the 
lead circumference would bring these stimulation limits into consideration. For DBSAs, 
monopolar single-cathode stimulation was useful for shifting the RoA CoM from lead-
center to 1.3 mm in the direction of the stimulating electrode. Shifting resolution on the 
scale of 0.1 mm was achievable with four radial electrodes using non-uniform 
distribution of current, suggesting a higher density DBSAs would not be needed to 
achieve clinically relevant RoA shifting if independent current sources are utilized. A 
simple feature set consisting of the RoA center of mass and orientation enabled robust 
machine learning classification with accuracy equal to 1 for a range of monopolar 
stimulation settings. 
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3.1.Overview 
3.1.1. Objective 
The goal of this study was to validate predictions from a series of computational models 
using in vivo electrophysiological recordings and behavioral assessment during deep 
brain stimulation of the globus pallidus internus. 
3.1.2. Approach 
Stimulation thresholds for evoking motor contractions during globus pallidus internus 
deep brain stimulation were evaluated in two non-human primates, one with a 
miniaturized DBS lead and one with a DBS array. In the subject with the DBS array, 
cortical recordings were used to generate a prediction of percent activation within the arm 
representation of the corticospinal tract. Subject-specific computational models using the 
scaled eigenvalue, the volume constraint, and the normalized volume constraint methods 
to represent tissue conductivity were constructed and used to predict activation within the 
arm representation of the corticospinal tract. Model results using the three different 
methods were compared to motor contraction thresholds and, in one subject, compared to 
stimulation induced cellular activation measured in motor cortex. 
3.1.3. Main Results 
Stimulation induced activation in motor cortex at the motor contraction threshold 
amplitude was measured within the range of 8-16% for distal electrodes and 0% for most 
proximal electrodes. Motor contractions were able to be induced using all electrodes, but 
higher stimulation amplitudes were required for increasingly proximal electrodes. In 
comparison to motor contraction thresholds, model predictions using the DBS array 
strongly over predicted the degree of directional steering. Error between model 
predictions and motor cortex recordings was lowest for models that relied on the 
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normalized volume constraint and was largest for models that relied on the scaled 
eigenvalue method. 
3.1.4. Significance 
The finding that the normalized volume constraint method for modeling brain tissue 
conductivity generated model predictions that best align with experimental data has 
important implications for the DBS modeling community, which has in the past relied 
primarily on the scaled eigenvalue method for modeling brain tissue conductivity. 
Additionally, the misalignment between behavioral outcomes and model predictions 
suggests that more comprehensive and anatomically correct representations of model cell 
distributions may be required to generate clinically relevant model outcomes.  
3.2.Background 
The clinical success of deep brain stimulation (DBS) therapy largely depends on the 
accuracy of DBS lead implantation and the degree to which stimulation settings can be 
adjusted without eliciting adverse side effects. Computational models of DBS that 
integrate both predictions of the induced electric field in brain tissue and predictions of 
biophysical neuron responses to electric fields [122] have provided notable successes in 
advancing DBS therapy. These models have supported (1) studies investigating the 
therapeutic mechanisms of DBS in preclinical animal models [99,163,164] and in 
humans [8,65,68,144,165] (2) development of neurosurgical planning software [69], (3) 
retrospective identification of neural pathways underlying side effects of DBS [66,67], 
(4) prospective approaches to optimize stimulation settings on an individual basis 
[114,115], and designing and evaluating novel DBS lead and stimulation technology [70–
72]. While such modeling efforts rely on bioelectric principles and assumptions that have 
been characterized in part in vivo [66,86], the overall modeling framework has yet to 
undergo rigorous behavioral and electrophysiological validation.  
To date, the most advanced models of DBS attempt to accurately incorporate subject-
specific brain anatomy at submillimeter resolution using high-field magnetic resonance 
imaging [148]. Such imaging approaches provide important context for constructing 
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inhomogeneous and anisotropic conductivity maps of brain tissue as well as 
morphological rendering of fiber tracts within the brain using diffusion weighted imaging 
[166–169]. Finite element models incorporating these conductivity maps in the context of 
a subject’s DBS lead implant(s) are then integrated with multi-compartment equivalent 
circuit models of neurons and fiber tracts. This framework thus facilitates predicting 
transmembrane currents imposed by stimulation [93,94,170,171] and whether or not 
those perturbations result in stimulation-induced action potential generation or other 
modulation of ongoing neuronal activity [8,172]. 
Quantification of the population response to stimulation is generally made using either a 
VTA or an activation profile curve. VTAs specific to an electrode or stimulation 
waveform can be created and overlaid onto medical imaging to visualize brain regions 
that may be modulated by different stimulation configurations. An activation profile 
represents a percent of neurons activated within a specific fiber tract or brain region by a 
particular stimulation configuration. Percent activation can be a useful measure for 
optimizing stimulation parameters, particularly in situations where side-effect regions 
cannot be completely avoided. Because of their complexity, many parameters contribute 
to the predictions from these models and although individual aspects of these models 
have been examined, such as the FEA tissue voltage predictions in the subthalamic 
nucleus area and thalamus [86], the VTA and activation profile approaches have yet to be 
rigorously validated.  
The goal of this study was to evaluate computational model predictions by comparing 
activation profiles from various tissue conductivity maps to in vivo electrophysiological 
recordings and behavioral assessments in the context of globus pallidus internus (GPi) 
deep brain stimulation leads. Two non-human primates were chronically implanted with 
either a DBS lead consisting of eight stacked cylindrical electrodes [99] or a radially 
segmented deep brain stimulation array (DBSA) [134]. In both cases, stimulation was 
delivered at amplitudes above and below the threshold for evoking muscle contractions 
resulting from putative activation of the adjacent corticospinal tract (CST) of the internal 
capsule (IC). The choice of the GPi target, as opposed to the subthalamic nucleus (STN) 
 44 
for example, was motivated by the fact that the GPi (unlike the STN) does not have direct 
projections two or from the cortex. In one primate, single cell recordings in the arm 
representation of motor cortex (M1arm) were acquired during stimulation using a 100-
channel microelectrode array. Cortical recordings were analyzed in order to identify 
stimulation induced antidromic activity, from which a percent activation of the arm 
representation within internal capsule was inferred. Additionally, subject-specific 
computational models of DBS were generated for each primate in order to compare 
predictions to muscle contraction thresholds (both subjects) and M1arm recordings (one 
subject). 
3.3.Methods 
3.3.1. Experimental procedure 
3.3.1.1.Subjects 
Two rhesus macaque monkeys, macaca mulatta, were subjects in this study: Monkey N 
(18 year old female, naïve) and Monkey J (15 year old female, rendered parkinsonian 
with the neurotoxin 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine, MPTP [157]). Both 
animals took part in other parallel studies and the modeling results were retrospective in 
context. All procedures were performed in compliance with the United States Public 
Health Service policy on the humane care and use of laboratory animals, and were 
approved by the University of Minnesota Institutional Animal Care and Use Committee. 
3.3.1.2.Preoperative imaging 
Preoperative MRI was acquired using a passively shielded 7 Tesla magnet (Magnex 
Scientific) at the University of Minnesota Center for Magnetic Resonance Research. 
Subjects were anesthetized with Isoflurane (2.5%) and monitored for depth of anesthesia 
during imaging sessions. Imaging acquisition included computed tomography (CT), T1-
weighted imaging (T1-W), T2-weighted imaging (T2-W), susceptibility-weighted 
imaging (SWI), and diffusion-weighted imaging (DWI) (Table 3). SWI was acquired 
with a 3D flow-compensated gradient echo sequence. 
Table 3. Subject and imaging sequence information  (iso: isometric). 
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Subject Sex Age 
(years) 
Anatomical imaging Diffusion weighted imaging 
T1-W 
(mm3) 
T2-W 
(mm3) 
SWI 
(mm3) 
b-value 
(s/mm2) 
# of 
directions 
FOV 
(mm3) 
Resolution 
(mm3) 
J F 15 0.469×0.469
×0.5 
0.357×0.357
×0.8 
0.4 iso 1500 132 144×88×
50 
1.1 iso 
N F 18 0.469×0.469
×0.5 
0.5 iso 0.4 iso 1500 110 144×88×
50 
1.1 iso 
3.3.1.3.DBS chamber placement 
Microelectrode mapping of the brain and DBS lead implantation were guided using 
surgically implanted chambers. A coordinate system was established using the surgical 
planning software, Cicerone (Miocinovic et al., 2007), by co-registering preoperative CT 
of the cranium and anatomical MRI of the brain in AC-PC space. The zero coordinate in 
AC-PC space was defined as the midpoint of an imagined line in the brain’s sagittal plane 
connecting the anterior and posterior commissure tracts. Coordinates for the chamber 
implant location were determined by aligning the central axis of chamber with the GPi. 
Chambers and head restraints were implanted during an aseptic surgical procedure as 
described previously [99,174]. Briefly, craniotomies were made under stereotactic 
guidance leaving the underlying dura intact, and cephalic recording chambers were 
secured in place using a combination of surgical bone screws and dental acrylic. Subject J 
was implanted with one chamber oriented along the parasagittal plane at an anterior angle 
of 38 degrees to target the GPi. Subject N was implanted with a chamber oriented along 
the coronal plane at a lateral angle of 32 degrees, with the latter used for targeting the 
sensorimotor external and internal segments of globus pallidus. 
3.3.1.4.Mapping, lead implantation, and postop imaging 
Microelectrode mapping of the brain was used to determine the precise lead implant 
location using techniques similar to those using in human functional neurosurgery [175]. 
The borders of the GPi were mapped in each subject by recording cell activity using 
tungsten microelectrodes that were advanced through uniformly spaced grid sections in 
the cephalic chambers (Narishige Scientific Instruments). The GPi and subregions within 
the GPi were identified by their characteristic firing patterns in response to sensorimotor 
manipulation [176]. Microstimulation (10–100 μA) was used to identify the corticospinal 
tract of IC. Once the boundaries of the GP were established and sensorimotor territory 
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identified, a final recording track was performed to determine the target depth for lead 
implantation. The tungsten microelectrode was then removed and the DBS lead was 
implanted to the target depth using an insertion cannula (Subject J) or stylet (Subject N). 
Subject J was implanted with a 0.625 mm diameter eight electrode lead (NuMED, 
Hopkinton, NY). Each cylindrical shell electrode was 0.625 mm in diameter, 0.5 mm tall, 
and separated by 0.5 mm (Figure 12, top left). Electrode contacts were labeled 0 (distal) 
through 7 (proximal). Subject N was implanted with a 0.6 mm diameter 32 electrode 
DBSA [134] (Figure 12, bottom left). DBSA electrodes were arranged with eight rows 
distributed along the length of the lead and separated by 0.28 mm. Each row consisted of 
four columns separated by 90 degrees. Each electrode was elliptical (0.36 x 0.47 mm) 
with the major axis aligned with the length of the lead body. The final lead location was 
verified using post-operative CT, which was acquired approximately one week after the 
lead implant procedure and co-registered to preoperative MRI (Figure 13). 
In a separate surgical procedure after DBS implantation, the right hemispheric arm 
representation in primary motor cortex (M1arm) of Subject J was implanted with a 96-
channel Utah microelectrode array (Figure 12, right) (Pt-Ir, 1.5 mm depth, 0.4 mm inter-
electrode spacing, Blackrock Microsystems) using methods described previously 
[177,178]. M1 was identified by sulcal landmarks (i.e. central sulcus, arcuate sulcus and 
precentral dimple) and the arm representation was identified through intra-operative 
stimulation of the cortical surface using a stainless steel ball electrode (Grass 
Technologies Corporation). 
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Figure 12. Stimulation and recoding implants. Subject J was implanted with an eight 
cylindrical electrode DBS lead (top left) and a 96-channel Utah microelectrode array 
(right). Subject N was implanted with a 32 ellipsoidal electrode DBS array (bottom left). 
 
 
Figure 13. Image co-registration and model lead placement. Preoperative MRI was co-
registered with postoperative CT in order to confirm the location of the implanted lead 
(left). The lead, the globus pallidus (GP), and the arm representation within the 
corticospinal tract (CSTarm) were constructed for each subject (right).  
3.3.1.5.Assessment of thresholds for stimulation-induced motor contractions 
Subjects were trained to allow passive manipulation of the limbs using positive 
reinforcement techniques. Stimulation pulse trains were delivered through each electrode 
at varying amplitudes in order to determine electrode-specific stimulation thresholds for 
inducing involuntary motor contractions in each subject. Current-regulated charge-
balanced waveforms were delivered using an external waveform generator and a current 
isolator (Subject J: IZ2H, Tucker Davis Technologies; Subject N: S88X, Grass 
Instruments with a Model 2200, A-M Systems,). Two slightly different stimulation trains 
were used for the two subjects. For Subject J, the stimulation pulse consisted of an 80 
sec cathodic pulse followed immediately by an anodic pulse with equal width and 
amplitude. In Subject N, the stimulation pulse was a 90 sec cathodic pulse followed by a 
20 sec interstimulus interval and then a 90 sec anodic pulse with equal magnitude to 
the initial cathodic pulse. Both subjects received monopolar stimulation with the cranial 
chamber serving as the return electrode. Stimulation thresholds for evoking motor 
contractions were determined in a blinded manner such that the observing researcher was 
unaware of the stimulation settings while evaluating the presence of involuntary muscle 
contractions. For Subject N, motor contraction thresholds were collected using 16 
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electrode configurations. Each configuration included two impedance matched electrodes 
in the same column that were electrically shorted such that stimulation was delivered 
simultaneously through both electrodes. In Subject J, stimulation was delivered using 
electrodes 0 (distal) through 5 (proximal). 
3.3.1.6.Quantification of electrophysiological recordings 
In Subject J, electrophysiological recordings were collected from the M1arm 
microelectrode array a TDT workstation (RZ2 DSP, PZ5 Neurodigitizer, Tucker Davis 
Technologies), with both recording and stimulation operating on the same ~25 kHz 
sample clock. The cortical microelectrode recordings were acquired for DBS amplitudes 
approximately 75%, 100%, and 125% of the motor contraction stimulation amplitude 
threshold for each electrode. Cortical recording trials consisted of a baseline off-DBS 
period (~30 sec in duration), followed by an on-DBS block at each of the three 
stimulation amplitudes. Each block consisted of a 5 second stimulation period, followed 
by 5 seconds off stimulation, repeated 5 times.  Raw data were filtered 0.5 Hz-12.5kHz 
and saved to hard disk for offline analysis. The following processing steps were 
performed for each of the 96 microelectrode array channels. First, a digital bandpass filter 
(300 Hz-3 kHz) was used to extract spike activity from the raw recording (Figure 14A). 
Second, DBS artifacts present in the recording were removed by a simple blanking 
procedure (Figure 14A). The preamplifier used had a large ±500 mV input range and 
artifacts did not cause saturation, so the artifact duration was brief (0.5-1 ms) and was 
removed by setting sample points during this period to zero. Third, spikes outside of 
background activity were identified in Offline Sorter (Plexon, Inc., Dallas, Texas, USA) 
based on a spike detection threshold set manually for each channel, ≥6 standard 
deviations below mean of the peak-heights histogram. Spike times typically reflected the 
activity of 1-3 cells and were saved for subsequent analysis. Recording channels with no 
clearly discernable cells outside the background (45 of 96 channels) were excluded. 
Finally, a peristimulus time histogram (PSTH, bin size = 0.2 msec) triggered to 
stimulation pulses was examined for each electrode configuration and stimulus amplitude 
and classified as putative antidromic based on whether short latency, low temporal jitter, 
high firing activity was detected following the DBS pulses (Figure 14B). The qualifier 
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“putative” is used because classification is based solely on the PSTH, and collision 
experiments were not conducted to confirm that DBS-evoked activity was definitively 
antidromic. The firing rate in each PSTH bin was converted to a z-score relative to 
baseline firing rate bins taken from the off-DBS period, based on a PSTH triggered to 
virtual stimulation pulses. If there was a peak in the resulting PSTH with a maximum z-
score >10, latency <3 msec, and low temporal jitter (width at half-max ≤3 bins), the 
stimulation evoked activity was classified as putative antidromic. This analysis is based 
in part on the assumption that neural recordings included activity from layer V pyramidal 
cells with axonal projections making up part of the internal capsule, which is not 
unreasonable given the electrode array depth of 1.5mm and the fact that putative 
antidromic activity was observed on many recording channels. The percentage of 
recording channels with putative antidromic activity was calculated (Figure 14C) and 
used for comparison to model predictions. 
 
Figure 14. Antidromic activity detected in M1 during GP stimulation. (A) Example raw 
(top) and processed (bottom) signal from one of the channels on the 96 channel M1 
microelectrode array, illustrating a putative antidromic firing in response to GP DBS. (B) 
Peristimulus time raster plots and histograms time locked to stimulation pulses (time = 0) 
were created for each recording channel and classified as antidromic or not as described 
in the Materials and Methods. (C) Illustration indicating the location of the M1 array on 
the cortical surface. Gray squares indicate channels with detectable single or multi-unit 
spiking activity (51/96 channels). For each stimulation configuration, neuronal responses 
to DBS at current levels of 75, 100, and 125% CST were characterized and the 
percentage of channels with antidromic responses was calculated. Additional plots show 
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channels with antidromic spike activity (orange) at each current level for the Monopolar 
C1 DBS configuration. 
3.3.2. Computational modeling 
Subject-specific computational models of DBS were constructed such that lead geometry, 
stimulation waveform, and stimulation configuration were consistent with those used 
during the assessment of stimulation induced muscle contractions in the two subjects. 
Each computational model included a finite element model of the brain and a population 
of multi-compartment axon cable models representing reconstructions of the arm 
representation within the corticospinal tract of internal capsule (CSTarm). Several versions 
of the finite element model were created in order to evaluate the effect of increased 
model complexity and different approaches for calculating anisotropic tissue conductivity 
maps. 
3.3.2.1.Image registration, brain segmentation, and lead placement 
Three-dimensional brain reconstructions and the placement of leads in each model were 
performed using co-registered pre- and postoperative subject imaging. A common 
coordinate system was established in DWI-space by aligning preoperative MRI and 
postoperative CT to the DWI dataset using Amira v6.0 (FEI, Hillsboro, OR). Digital 
representations of the implanted lead and chamber were aligned to the co-registered 
imaging data using Cicerone (Miocinovic et al., 2007) (Figure 15A). From the co-
registered T1-W, T2-W, and SWI data, the brain white matter, gray matter, and the lateral 
ventricles were manually segmented using Mimics v15.0 (Materialise, Leuven, Belgium) 
(Figure 15B). Regions modeled as gray matter included the cortical and cerebellar gray 
matter, the basal ganglia, and thalamus. A digital representation of the chamber and lead 
were placed in reference to the co-registered postoperative CT data. 
3.3.2.2.Tissue conductivity tensor maps 
Subject specific tissue conductivity tensor maps were calculated using three approaches 
(Sections 3.3.2.2.1-3.3.2.2.3), each of which relied on diffusion tensors estimated from 
DWI (Figure 15C). Processing of the DWI was performed using FSL [179] and included 
eddy current correction using FDT [180], brain extraction using BET [180], estimation of 
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diffusion parameters using BEDPOSTX [181], and fitting of the diffusion tensor model at 
each voxel using DTIFIT [181]. The diffusion tensor eigenvalues and eigenvectors 
calculated using DTIFIT were used in the calculation of the tissue conductivity tensors at 
respective voxels. The term, tissue conductivity tensor map, referred to the entire set of 
tissue conductivity tensors calculated at each DWI voxel for a single subject. At each 
voxel, a tissue conductivity tensor (Σ) was calculated from its eigendecomposition: 
Σ = 𝑉𝜎𝑉𝑇     (23) 
where V is the matrix of tensor eigenvectors and σ is the diagonal matrix of conductivity 
tensor eigenvalues. Tissue conductivity tensor eigenvectors were assigned as equal to the 
diffusion tensor imaging eigenvectors [182].  In two of the approaches, isotropic 
conductivity and relative permittivity for gray and white matter were calculated using the 
Gabriel et al. Cole-Cole dispersion functions [83]. For the models that fully incorporated 
dielectric dispersion, tissue properties were calculated at frequencies between 1 kHz and 
512 kHz at 1 kHz increments. For all other models, tissue properties were calculated at 
the estimated median normalized frequency of a single stimulation pulse (Table 4). In all 
approaches, gray matter was assumed isotropic, and cerebrospinal fluid (CSF) was 
assumed isotropic, frequency independent, and purely resistive (σ = 1.79 S/m, ɛr = 0) 
[183]. 
 
Table 4. Isotropic tissue properties at the stimulation pulse median estimated frequency 
for each subject. 
 
Subject 
Stimulation 
pulse estimated 
median 
frequency (Hz) 
Gray matter White matter 
Conductivity 
(S/m) 
Relative 
permittivity 
Conductivity 
(S/m) 
Relative 
permittivity 
J 5530 0.110 38570 0.067 19452 
N 4200 0.108 49600 0.066 23734 
 
3.3.2.2.1. Scaled eigenvalue (SE) conductivity tensor map 
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The scaled eigenvalue (SE) conductivity tensor map was calculated using the linear 
cross-property relationship between conductivity and diffusion tensors [88]. The tissue 
conductivity tensor eigenvalues were calculated by scaling the diagonal matrix diffusion 
tensor eigenvalues (λ1, λ 2, and λ 3) by a factor s: 
𝜎 = 𝑠 ∗ [
𝜆1 0 0
0 𝜆2 0
0 0 𝜆3
]    (24) 
where s was 0.844 S s/mm
3
. The resulting diagonal matrix of conductivity tensor 
eigenvalues (σ) was used in Equation 23 to calculate the tissue conductivity tensor (Σ) for 
each voxel.  
3.3.2.2.2. Normalized volume (NV) conductivity tensor map 
The normalized volume (NV) conductivity tensor map [90,149] was calculated by scaling 
each diffusion tensor eigenvalue (λi) by the ratio of the geometric volume of the isometric 
conductivity tensor to the geometric volume of the diffusion tensor:  
𝜎𝑖 =
4
3
𝜋 ∗ 𝜎𝑖𝑠𝑜
3
4
3
𝜋 ∗ 𝜆1𝜆2𝜆3
𝜆𝑖    () 
where σiso is the isometric conductivity of white matter and λ1, λ2, and λ3 are the tensor 
primary, secondary, and tertiary eigenvalues. The diagonal matrix of conductivity tensor 
eigenvalues (σ): 
𝜎 = [
𝜎1 0 0
0 𝜎2 0
0 0 𝜎3
]    () 
was used in Equation 23 to calculate the tissue conductivity tensor (Σ) for each voxel. 
3.3.2.2.3. Volume constraint (VC) conductivity tensor map 
 53 
The volume constraint (VC) conductivity tensor map, described previously by [89], 
was calculated by constraining the geometric volume of the anisotropic conductivity 
tensor to equal the geometric volume of the anisotropic conductivity tensor:  
4
3
𝜋𝜎∥𝜎⊥
2 =
4
3
𝜋𝜎𝑖𝑠𝑜
3      () 
where σ∥ is the conductivity of white matter in the direction parallel to a fiber tract, σ⊥ is 
the conductivity of white matter in the direction perpendicular to a fiber tract, and σiso is 
the isotropic conductivity of white matter. The ratio of parallel to perpendicular 
conductivity (r) was used to calculate conductivity in both directions: 
𝜎∥ = √𝜎𝑖𝑠𝑜
3 𝑟2
3
      () 
𝜎⊥ = √
𝜎𝑖𝑠𝑜
3
𝑟
3
       () 
where r was 9 [84]. The calculated value for parallel conductivity was used as the 
primary conductivity tensor eigenvalue and the calculated value for perpendicular 
conductivity was used for both the secondary and tertiary conductivity tensor 
eigenvalues. The diagonal matrix of conductivity tensor eigenvalues (σ) was then used in 
Equation 23 to calculate the tissue conductivity tensor (Σ) for each voxel. 
Table 5. Anisotropic tissue properties at the stimulation pulse median estimated 
frequency for each subject. 
Subject 
Stimulation pulse 
estimated median 
frequency (Hz) 
White matter conductivity 
(S/m) 
Parallel Perpendicular 
J 5530 0.290 0.0322 
N 4200 0.286 0.0317 
3.3.2.3.Multi-compartment axon models 
Topographic subsections of the corticospinal tract of the IC were segmented through 
probabilistic tractography performed using FSL [179]. Probabilistic tractography was 
guided by seed and way masks that were defined within the T2-W images of each subject 
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in reference to an atlas of the rhesus macaque brain [184] and a reference text on the fiber 
tracts of the rhesus macaque brain [185]. A seed mask was created in the right 
hemispheric M1arm and a way mask was created within the right hemispheric internal 
capsule, slightly posterior and ventral of the subthalamic nucleus (STN). Masks were 
transformed from the T2-W coordinate system into the diffusion coordinate system using 
FLIRT [180,186] in FSL. The transformed mask and the output of BEDPOSTX (Section 
3.3.2.2) were used by PROBTRACKX [187] in FSL to produce probabilistic maps of the 
region of the internal capsule that projects from M1arm to the spinal cord.  A digital 
rendering of the CSTarm was generated by thresholding the probabilistic tractography map 
in reference to the previously cited reference text on the fiber tracts of the rhesus 
macaque brain [185]. The surface reconstruction was then used to guide construction of a 
population of multi-compartment axons (Figure 15D).  
Each fiber tract reconstruction was pseudo-randomly populated with 1000 multi-
compartment axon models. Results from simulations with 100 to 1000 axons were 
compared and the resulting activation profiles converged to within 1% when 500 or more 
axons were modeled. To prevent artifacts relating to model axon density the full 
population of 1000 axons were used in subsequent stimulations. The population of multi-
compartment axons was constrained by cross-sectional contours from the digital surface 
reconstruction of the CSTarm. Axial contours separated by 5 mm were generated using 
Rhinoceros3D v4.0. Each contour was discretized into 100 points and the coordinates of 
these points were imported to Matlab R2015a. Using Matlab, each contour was populated 
with 3000 randomly distributed points. Splines connecting the nearest points from 
neighboring contours were calculated and the first 1000 splines were used to define the 
geometries of the 1000 modeled axons. Axons were modeled with a myelinated diameter 
of 2 µm in alignment with measurements taken from the internal capsule in the rhesus 
macaque [121]. Each axon was populated with compartments representing nodes of 
Ranvier, myelin attachment segments, paranode main segments, and internode segments 
connected by an axial resistance. Axon compartment properties and order were consistent 
with the multi-compartment axon cable model developed previously [99,122,147,164].  
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Figure 15. Brain tissues were segmented manually and multi-compartment axon tracts 
were created using probabilistic tractography. Preoperative MRI was co-registered with 
postoperative CT (A). Gray matter, white matter, and the lateral ventricles were 
segmented using the co-registered MRI, and a digital representation of the DBS lead was 
placed in accordance with the co-registered postoperative CT imaging (B). Probabilistic 
tractography was performed using DWI (C) to segment the CSTarm within the right 
hemisphere (D). The segmented region of the internal capsule was used to guide the 
pseudorandom creation of 1000 multi-compartment axon geometries.  
 
3.3.2.4.Finite element model 
A finite element model was created for each subject in Comsol Multiphysics v5.2. 
Each model was created in alignment with the original DWI coordinate system so that no 
transformation of the tissue conductivity tensor map was required.  
3.3.2.4.1. Model geometry 
The geometry of the model included a smoothed reconstruction of the subject’s brain, a 
surface representation of the cephalic chamber, the DBS(A) lead. A reconstruction of 
each brain was smoothed to the extent that the cortical sulci were no longer visible on the 
surface. The smoothed brain was used in order to simplify meshing while maintaining the 
overall shape. Brain reconstructions were imported using Comsol Multiphysics CAD 
import module. The cephalic chamber was represented as distinct region on the surface of 
the brain as a circle with an outer diameter of 1 cm. It should be noted that in the 
experimental preparation, the cephalic chamber rests on the skull; however, granulation 
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tissue and residual fluid provide a conductive path between the chamber and brain. The 
DBS(A) lead was manually constructed within Comsol and included the lead body, the 
electrodes, and a 0.1 mm thick encapsulation layer. The location and orientation of the 
chamber and lead were determined using postoperative CT imaging. Depending on model 
complexity, the lead and electrodes were either included as volumetric entities or 
subtracted from the surrounding volume, leaving surface representations of the lead and 
electrodes. 
3.3.2.4.2. Boundary conditions 
The surface representation of the cephalic chamber was assigned as ground via the 
Dirichlet boundary condition of zero volts. The remainder of the brain surface was 
assigned the Neumann boundary condition of zero flux. In models where the lead and 
electrode geometries were modeled as surfaces rather than volumes, the lead body and 
inactive electrodes were assigned the Neumann boundary condition. Depending on model 
complexity, current-regulated stimulation was applied as a normal current density or 
using an equivalent circuit model of the electrode tissue interface (ETI). Both methods 
were implemented as boundary conditions on the surface of the stimulating electrode(s). 
In the case of the DBSA, the stimulation amplitude was evenly split across paired 
electrodes. Normal current density was calculated by dividing the maximum stimulation 
amplitude by the geometric surface area of the electrode. The equivalent circuit model 
was applied as a terminal boundary condition using the Comsol Multiphysics AC/DC 
module. The electrode tissue interface (ETI) was modeled as a three element Randles 
equivalent circuit model connected to a current-regulated source. The equivalent circuit 
model consisted of an access resistance, Ra, in series with a faradaic resistance, Rf, and 
double layer capacitance, Cdl connected in parallel. Ra was calculated by assigning 1 volt 
to the stimulating electrode (via the Dirichlet boundary condition), using Comsol to 
calculate normal current density during stimulation, calculating the effective applied 
current by integrating across the electrode surface, and dividing the stimulation voltage 
by the effective applied current. Rf was calculated by dividing the distributed faradaic 
resistance of platinum electrodes (150 Ω-cm2 [119]) by the electrode surface area. Cdl 
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was calculated by multiplying the electrode surface area by the distributed double layer 
capacitance of platinum electrodes (30 μF/cm2 [119]).  
3.3.2.4.3. Mesh 
Meshing was performed via Delaunay triangulation using Comsol. Mesh element size 
and growth parameters for the brain were varied depending on model complexity. To 
account for the small size and radius of the lead, electrodes, and encapsulation layer, the 
minimum and maximum mesh element size of these model domains was 0.01 and 0.1 
mm. A small-domain mesh refinement study was performed for these small domains and 
further refinement of the mesh changed the average FEA results by less than 1%. The 
shape function order used was the Comsol default (quadratic) except where specified 
otherwise. 
3.3.2.4.4. Material properties 
Text files containing the brain tissue conductivity tensor maps and relative permittivity 
values at a given frequency were automatically imported to Comsol as spatially 
dependent variables using the Comsol module, Livelink with Matlab. The tissue 
properties of the brain were assigned by interpolating the tissue conductivity tensor map 
and relative permittivity onto the finite element mesh using the nearest neighbors 
function. The encapsulation layer conductivity and relative permittivity were assigned 
isotropic values of white matter in order to represent the presence of a glial scar [155]. In 
models where the lead and electrodes were included as volumes, the material properties 
were assigned in accordance with previous DBS modeling work (lead body: σ = 1e-13, ɛr 
= 2) and (electrodes: σ= 5e-6, ɛr = 1) [188,189]. 
3.3.2.5.Predicting stimulation induced axonal activation 
3.3.2.5.1. The Fourier finite element method (FFEM) 
The Fourier finite element method (FFEM), described by Butson and McIntyre [190], 
was used to incorporate reactive tissue components and dielectric dispersion, both of 
which have been shown to significantly contribute to waveform shaping [190,191]. The 
FFEM was implemented as follows: A subject-specific stimulation waveform (1 msec in 
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duration and discretized into 1024 points) was created in Matlab (Figure 16A). The 1024 
point discrete Fourier transform (DFT) of the stimulation waveform was calculated using 
Matlab, producing estimates of the stimulation pulse phase and magnitude at 513 
frequencies: 0 through 512 kHz at 1 kHz increments (Figure 16B,C). At the same 513 
frequencies, the FEA was used to solve the time harmonic electroquasistacic equation: 
−∇[𝜎(𝜔) + 𝑗𝜔𝜀0𝜀𝑟(𝜔)]∇Φ = 0    () 
where σ is conductivity, ω is angular frequency, ɛ0 is the permittivity of free space (8.85 
x 10
-12
 F/m), ɛr is relative permittivity, and Φ is scalar electric potential. FEA was 
performed using the direct MUltifrontal Massively Parallel sparse direct Solver 
(MUMPS) in Comsol Multiphysics v5.2 on clusters at the Minnesota Supercomputing 
Institute at the University of Minnesota. In the dielectric dispersion model, tissue 
property maps were incorporated that were consistent with the frequency being solved. In 
all other models, the tissue property maps were consistent with the estimated normalized 
median frequency of the stimulation pulse regardless of the frequency being solved. The 
real and imaginary components of the calculated tissue potential (Figure 16D,E) were 
interpolated at the three-dimensional coordinate of each axon compartment using Comsol 
LiveLink with Matlab. A stimulation waveform for each compartment of each axon 
model was reconstructed by scaling the simulation pulse DFT by the compartment 
potential at each frequency, and performing the inverse DFT on the result (Figure 16F). 
The resulting waveform was duplicated and concatenated nine times to create a ten pulse 
stimulation train at 130 Hz.  
3.3.2.5.2. Multi-compartment axon modeling 
Stimulation pulse trains were simultaneously played into each compartment of a given 
axon using the NEURON v7.3 programming environment [192]. This was performed by 
perturbing the axonal membrane voltage using the extracellular mechanism 
(e_extracellular), in a manner consistent with previous modeling work [193]. Using 
NEURON, action potential counters were attached to each node and simple thresholding 
was used to detect stimulus driven spike activity. An axon was considered ‘activated’ if 
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an action potential was detected within 3 msec following 80% of stimulation pulses. 
Stimulation amplitude was varied until the threshold for activation was narrowed to a 
window of +/-0.05 mA. Activation profiles were then created for using all 1000 axons 
(Figure 16G).  
 
Figure 16. Axonal activation was modeled using the Fourier finite element method. The 
1024-point discrete Fourier transform (DFT) of the stimulation pulse (A) was used to 
calculate magnitude (B) and phase (C). The time harmonic Laplace equation was solved 
in the frequency domain using FEA at each frequency represented within the stimulation 
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pulse DFT (D and E). The stimulation pulse DFT was scaled by the FEA result at the 
location of each axon model compartment and the inverse DFT was performed to 
generate a compartment-specific stimulation pulse (F). Simulations of multi-compartment 
axons exposed to trains of compartment-specific stimulation pulses were performed using 
the NEURON programing environment and used to generate activation profiles (G) for 
each electrode stimulation configuration. 
3.3.3. Model comparison to experimental data 
For both subjects, model predictions were compared to in vivo motor contraction 
thresholds for stimulation through each electrode by calculating percent error. Percent 
error was calculated between the motor contraction stimulation amplitude threshold and 
the model-predicted stimulation amplitude required to achieve 10, 15, and 20% 
activation, per the activation profile curve. This resulted in three values for percent error, 
which were calculated for each conductivity map. In Subject J, model predictions using 
each conductivity map were compared directly to in vivo cortical recording results by 
calculating root mean squared error (RMSE) across trials. Each trial consisted of 
stimulation through a single electrode at a specific stimulation amplitude. As described 
previously, stimulation was delivered using C0 through C5 at three different stimulation 
amplitudes resulting in 18 trials. Error was calculated for each trial (indicated by the 
subscript i) as the difference between the calculated percentage of experimentally 
recorded M1arm cells with putative antidromic activity (yi) and the model-predicted 
percent activation (𝑦?̂?) during stimulation.  
𝑅𝑀𝑆𝐸 = √
1
𝑛
∑ (𝑦𝑖 − ?̂?𝑖 )2
𝑛
𝑖=1      () 
where n is the number of trials. 
3.4.Results 
3.4.1. GPi-DBS motor contraction thresholds and electrophysiology in M1arm (Subject 
J) 
GPi-DBS induced motor contractions in the contralateral upper extremity of Subject J 
(Table 6), including elbow, wrist, and finger flexion and extension. Stimulation 
thresholds for inducing muscle contractions were higher for electrodes located proximally 
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along the DBS lead, which not surprisingly corresponded to the electrodes with the 
largest spatial separation to the CST. 
Table 6. Subject J motor contraction stimulation amplitude thresholds and M1arm percent 
activation. 
Electrode 
Motor contraction 
stimulation 
amplitude 
threshold (mA) 
Motor contraction 
Percent activation 
calculated from 
M1arm recordings 
(%) 
C5 0.8 Elbow extension 0 
C4 0.7 Finger extension 0 
C3 0.6 Elbow extension 8 
C2 0.5 Elbow extension 10 
C1 0.3 Elbow flexion 16 
C0 0.2 Elbow flexion 12 
Zero percent M1arm activation was recorded at the motor contraction stimulation 
amplitude threshold of the two most proximal electrodes, C4 and C5. Across electrodes 
C0 through C3, the average percent activation recorded from cortex at the motor 
contraction threshold was 11.5 percent. For the electrodes where stimulation at the motor 
contraction threshold was greater than zero, C0 through C3, M1arm percent activation was 
impacted by electrode location and stimulation amplitude (Figure 17). For each electrode, 
increasing stimulation to 125% of threshold and decreasing stimulation to 75% of 
threshold increased and decreased M1arm percent activations respectively. For all 
electrodes, M1arm percent activation decreased for electrodes that were further from the 
target, but this effect was most dramatic for stimulation at 125% of threshold. 
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Figure 17. Motor contraction stimulation thresholds increased for more proximal 
electrodes. Percent activation of M1arm at the motor contraction stimulation threshold was 
highest and was within the range of 7-16 % for electrodes C0 through C3. 
3.4.2. GPi-DBS conventional lead model predictions (Subject J) 
DBS lead model predictions of activation (Subject J) using the three different 
conductivity tensor maps differed significantly within the stimulation amplitude range of 
0-1 mA (Figure 18). For stimulation using any of the four most proximal electrodes, zero 
percent activation was predicted for stimulation ≤1 mA. Additionally, simulations using 
the SE conductivity map failed to reach 10% activation for stimulation ≤1 mA using any 
electrode. Considering only the four most distal electrodes, the magnitude of the average 
difference between activation profiles produced using the NV and VC conductivity maps 
was 6 percentage points. The average difference between activation profiles produced 
using the SE conductivity map and the VC and NC conductivity maps were 40% and 
47%, respectively.  
For the purposes of analysis 10% activation was selected for detailed consideration based 
on the percent activation range that was calculated from cortical recordings (Table 6). 
Stimulation at 0.1 mA using the most distal electrode (C0) resulted in approximately 10% 
activation for both the NV or VC conductivity maps; however, the two model predictions 
diverged as stimulation amplitude increased. The difference in percent activation 
increased to approximately 15 percentage points at 1 mA with the NV map producing a 
higher prediction of activation. The difference in activation between models 
incorporating the NV and VC conductivity maps for stimulation using the C1 and C2 
electrodes was zero to five percentage points.  
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Figure 18. Activation profiles generated from models using the NV, VC and SE 
conductivity maps. Predictions of activation were significantly higher for the NV and VC 
conductivity maps in comparison to the SE map. 
3.4.3. DBS model validation in reference to cortical recording results (Subject J) 
Comparisons between percent activation from the M1arm recording array and model 
predictions of percent activation showed that models using the NV conductivity map 
produced results that best aligned with the experimental results in Subject J (Figure 19). 
Only stimulation using the three most distal electrodes: C0, C1, and C2 produced results 
where both model predictions of percent activation and M1arm calculations of zero 
percent activation were non-zero (Figure 19, left). The SE conductivity map performed 
poorest with a RMSE equal to 11.8. The NV conductivity map performed best with a 
RMSE equal to 6.08 (Figure 19, right). Prediction errors from the SE conductivity map 
were positive indicating the models under predicted percent activation. Prediction errors 
from the NV and VC conductivity maps were positive except for stimulation using C0 at 
75% and 100% of the motor contraction threshold and stimulation using C1. Considering 
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only electrodes C0, C1, and C3, the VC conductivity map modeling results produced 
slightly more accurate predictions of percent activation than the NV conductivity map in 
all cases except for the 75% and 100% of the motor contraction thresholds using C0.  
 
Figure 19. The NV conductivity map out performed both the SE and VC conductivity 
maps in terms of both RMSE and the coefficient of determination. The models under 
predicted activation except in the case of stimulation using C1 and stimulation using C0 
at 75% and 100% of the motor contraction threshold.  
3.4.4. Directional effects of GPi-DBS on motor contraction thresholds (Subject N) 
Directional stimulation induced motor contractions were observed in Subject N using the 
radially segmented DBS array (Figure 20). The observed motor contraction was flexion 
of the fingers. Stimulation thresholds were highest for stimulation configurations using 
electrodes facing away from internal capsule (anterior). The lowest stimulation thresholds 
were consistently from stimulation configurations that included only electrodes nearest 
internal capsule (posterior). The directional bias was greatest for the most distal 
electrodes and decreased for more proximal rows that were farther from the internal 
capsule, which is consistent with the results from Subject J described above. On average, 
the stimulation threshold was 30% higher for electrodes facing away from the internal 
capsule (anterior) than for electrodes facing the internal capsule (posterior). Additionally, 
the difference between the stimulation threshold from the column with the highest 
threshold and the column with the lowest threshold was 0.12 mA on average.  
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Figure 20. Motor contraction stimulation thresholds were observed to be lowest for 
stimulation through the posterior facing electrodes and highest for stimulation through 
the anterior facing electrodes. GP = globus pallidus, IC = internal capsule, A = anterior, P 
= posterior, M = medial, L = lateral. 
3.4.5. GPi-DBS array model predictions (Subject N) 
Similar to the conventional DBS lead model predictions, predictions of axonal activation 
with the DBS array differed significantly amongst the three different conductivity tensor 
maps (Figure 21). Within the 0-1 mA stimulation amplitude range, >10% activation was 
predicted only using the NV and VC tissue conductivity maps for the two most distal 
electrode groups and only for electrodes in the two columns closest to the IC. Simulations 
using the SE conductivity map failed to reach 10% activation for stimulation ≤1 mA 
using any electrode. Considering only the electrode configurations where >10% 
activation was predicted within 0-1 mA, the VC conductivity map predicted percentages 
that were 10-60 points higher that predictions produced using the NV conductivity map. 
Increasing the modeled stimulation amplitude range to 0-5 mA enabled for visual 
inspection of the model prediction trends and enabled quantification of the stimulation 
amplitude required to achieve 10% using the three most distal electrode groups as was 
done in the case of the conventional DBS lead modeling results. Within the 0-5 mA 
range, higher activation was predicted for the more distal electrode groups. For distal 
electrode groups, the activation profile plateaued when it neared 100% activation, while 
for more proximal electrode groups, the activation profiles were much more linear and 
did not plateau and/or did not near 100% activation.  
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The stimulation amplitudes needed to achieve 10% activation using the DBSA model 
were much higher than those using the DBS lead. For all electrode groups using both the 
NV and VC conductivity maps, the models predicted an extreme directional bias. Using 
any of the conductivity maps, stimulation within 0-5 mA using the most proximal 
electrodes did not result in predictions of at least 10% activation in all directions, and 
therefore, this group of electrodes was not plotted nor quantified in detail. Additionally, 
using the SE conductivity map, stimulation within 0-5 mA did not result in predictions of 
at least 10% activation in all directions for any of the electrode groups, and therefore, this 
group of electrodes was not plotted nor quantified in detail. On average, for both NV and 
VC conductivity maps, stimulation amplitude was approximately 300% higher for the 
electrode column with the highest required amplitude (anterior) in comparison to the 
electrode column with the lowest required stimulation amplitude (posterior). The range of 
the stimulation amplitude differential was smaller for the NV conductivity map (226-
365%) than for the VC conductivity map (150-503%). 
 
Figure 21. Model predictions of the stimulation amplitude required to reach 10% CSTarm 
activation models of Subject N using the NV and VC conductivity maps. Stimulation 
amplitudes predicted using the SE conductivity map was greater than 4 mA in at least one 
direction for each stimulating row, and therefore was excluded. 
3.4.6. DBS conventional lead model predictions versus motor contraction thresholds 
(Subject J) 
Model results were considered in the context of DBS lead motor contraction thresholds in 
two ways. First, by evaluating the model predicted percent activation at the motor 
contraction stimulation amplitude threshold using each conductivity map; and second, by 
calculating the percent error between the motor contraction stimulation amplitude and the 
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model predicted stimulation amplitude required to activate 10, 15, and 20% of modeled 
axons (Figure 22). Using the SE conductivity map, predictions at the motor contraction 
threshold were less than 5% for the most distal electrode (C0) and were zero for all other 
electrodes. For electrodes C0 through C2, model predictions using the NV and VC 
conductivity maps were within 5 percentage points; however, the predicted percent 
activation was not consistent across electrodes. Further, comparing the results from the 
NV or VC conductivity maps, neither produced a consistently higher or lower prediction 
of activation. Percent activation predicted using either the NV and VC conductivity maps 
fell within the following ranges C0: 16.4 to 19.8% | C1: 24 to 27.7% | C2: 5.5 to 9%. The 
lowest percent error between the motor contraction stimulation amplitude and the model 
predicted stimulation amplitude changed for different electrodes (Figure 22). For C0 and 
C1 the stimulation amplitude required to activate 20% of axons using either the NV or 
VC conductivity maps had the lowest error, while 10% activation using either the NV or 
VC conductivity maps resulted in the lowest error for C2. Where the models did not 
predict activation of at least 10% within the 0-1 mA range, 1 mA was used to calculate 
the minimum error. For C3, the magnitude of the minimum error using any of the three 
conductivity maps was greater than 67%. For the more distal electrodes: C0, C1, and C2, 
models using the SE conductivity map did not predict at least 10% activation within the 
0-1 mA range and, therefore, the minimum magnitude of the error was greater than 
100%. 
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Figure 22. Model predictions of percent activation at the motor contraction threshold. 
Using the SE conductivity map, activation was predicted to be < 3%. Activation 
predicted using the NV or VC map was 5-28% and neither map resulted in predictions of 
consistently higher predictions. The percent error between the motor contraction 
stimulation amplitude and the model predicted stimulation amplitude required to activate 
10, 15, and 20% exceeded 50% for all electrodes. Using the NV or VC map, error was 9-
10% comparing the motor contraction threshold to the model predicted stimulation 
amplitude required to achieve 20% activation. 
3.4.7. DBS array model predictions verses behavioral thresholds (Subject N) 
Model results using the DBS array were evaluated using the same methods that were 
utilized for the DBS conventional lead model comparison. For all but three stimulation 
configurations, the models predicted zero percent activation at the motor contraction 
threshold. Within these three configurations, only models using the VC conductivity map 
predicted greater than zero percent activation, and the model predictions were less than 
10%.  
The magnitude of percent error between the motor contraction stimulation amplitude and 
the model predicted stimulation amplitudes required to activate 10, 15, and 20% of 
modeled axons were much higher in all cases than the percent error calculated from 
models of the DBS lead ( 
Figure 23). Where the models did not predict activation of at least 10% within the 0-5 
mA range for all four directions, error was not plotted. These models included models 
that relied on the SE conductivity map, and models of simulation using the most proximal 
group of electrodes. The range of minimum errors from using the SE conductivity map 
was 650-1250% depending on electrode configuration. For all electrode configurations, 
percent error was lowest when comparing the motor contraction stimulation amplitude 
and the model predicted stimulation amplitude required to activate 10% of modeled 
axons using the VC conductivity map. Considering only the NV and VC conductivity 
maps using only the three most distal electrode groups, percent error was lowest, on 
average, for the most distal group of electrodes, which was closest to the CSTarm tract, 
and increased with distance as the electrode groups that were used were further from the 
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CSTarm tract. Additionally, percent error was lowest for electrodes in columns facing the 
CSTarm tract and increased strongly for electrodes facing away from the CSTarm tract. 
 
Figure 23. The magnitude of percent error between the motor contraction stimulation 
amplitude and the model predicted stimulation amplitude required to activate 10, 15, and 
20% of the CSTarm fibers. Note that posterior and lateral columns faced the CSTarm tract. 
3.5.Discussion 
Models of DBS have been increasingly utilized in research and clinical practice over the 
past two decades. To be properly utilized, it is important to understand the accuracy of 
model outcomes and to understand precisely how model predictions of cellular activity 
relate to behavioral outcomes. This understanding is vital in circumstances where models 
are used to guide clinical decision making. For example, in the scenario where models are 
used to guide or optimize stimulation parameters; a practice that may become necessary 
for next-generation DBS leads with many electrodes that cannot be feasibly programed 
using conventional trial-and-error programming strategies. Previous studies have 
compared computational modeling results to therapeutic effects and side-effects in 
patients [66,147] and preclinical animal models [99,148,164]. However, these studies are 
severely limited by the lack of model validation and the unclear relationship between 
model predictions of cellular activation and behavioral or clinical outcomes.  
Previous DBS computational modeling studies have established that subject-specific 
inhomogeneous and anisotropic tissue properties significantly impact model predictions 
[85,87]. This effect is due primarily to the inhomogeneous conductance of the brain as a 
whole and the close proximity of DBS target brain structures to highly anisotropic axon 
tracts such as the internal capsule. Several methods have been proposed within the brain 
 70 
modeling literature for calculating subject-specific anisotropic tissue conductivity maps 
[88–90]. With only a few exceptions, [149,194], DBS models have relied upon the 
method described by Tuch et al. for calculating subject-specific anisotropic tissue 
conductivity maps [66,147,148]. Comparative modeling studies using different methods 
for calculating subject-specific anisotropic tissue conductivity maps are rarely performed 
in the context of DBS and therefore model sensitivity to this parameter remains unknown.   
The results of our study include: (1) stimulation induced activation in motor cortex at the 
motor contraction threshold amplitude was measured within the range of 8-16% for distal 
electrodes and 0% for most proximal electrodes. (2) Motor contractions were able to be 
induced using all electrodes, but higher stimulation amplitudes were required for 
increasingly proximal electrodes. (3) In comparison to motor contraction thresholds, 
model predictions using the DBS array strongly over predicted the degree of directional 
steering. (4) Error between model predictions and motor cortex recordings was lowest for 
models that relied on the normalized volume constraint method and was largest for 
models that relied on the scaled eigenvalue method.  
3.5.1. Relating M1arm activity patterns to behavior 
In both subjects, the stimulation amplitude required to evoke muscle contractions 
increased for proximal electrodes and decreased for distal electrodes. This increase was 
most obvious and consistent in Subject J, where the threshold stimulation amplitude 
increased at increments of approximately 0.1 mA as the stimulating electrode was 
changed from one electrode to an adjacent and more proximal electrode. It was 
anticipated that regardless of which electrode was used for delivering stimulation, CSTarm 
predictions of activation from cortical recordings would be generally consistent if similar 
motor contractions were observed. However, CSTarm predictions were inconsistent 
between distal and proximal electrodes. On average, in Subject J, 11.5% activation within 
CSTarm was measured at the stimulation amplitude threshold using the four most distal 
electrodes. In contrast, 0% activation was measured during stimulation using the two 
most proximal electrodes. This result suggests that (1) the brain area within M1 covered 
by a single cortical array was not sufficient to capture the full extent of antidromic 
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CSTarm activation that resulted from stimulation and/or (2) stimulation of pathways other 
than the CSTarm were responsible for generating motor contractions during stimulation 
using the two most proximal electrodes. Alternative pathways that may have been 
stimulated include those at various levels within the CST, such as fibers from premotor 
cortex and supplementary motor area, which are known targets of cerebellar output [195–
197]. In this study, GPi was selected as the target rather than STN or thalamus in order to 
limit the potential for stimulating complex fiber pathways; however, projections to 
different cortical regions are not precisely segmented within the CST [185] making 
isolation of single CST subregion in this manner difficult.  
3.5.2. Relating M1arm activity patterns and behavior to model predictions  
Results from cortical recordings best aligned with model predictions of percent activation 
that were generated using the NV conductivity map. The error in SE map model 
predictions was found to be much higher than either the NV map or the VC map model 
predictions. Both the NV and VC maps were generated using DWI data in combination 
with the Gabriel dispersion model, suggesting that conductivity maps that leverage both 
inputs generate more accurate tissue conductivity maps. Comparing the VC and NV map 
errors, the different was smaller but the NV map generated a lower estimate of error. This 
finding indicates that the normalized DTI eigenvalues provide a better estimate of 
anisotropy in brain tissue conductivity than artificially imposed anisotropy using the 9:1 
ratio described by Nicholson in 1965 [84]. This outcome is perhaps not surprising as the 
measurements taken by Nicholson did not sample enough brain areas to generate an 
estimate of variance; however, this observation is notable considering that it is commonly 
cited used to define white matter anisotropy in models of the brain.  
Model predictions of activation at the stimulation thresholds for inducing motor 
contractions differed strongly between the DBS lead and the DBSA. NV map model 
predictions of activation during stimulation using the DBS lead (Subject J) were 19.8% 
for electrode C0, 24% for electrode C1, 9% for electrode C2 and 0% for all other 
electrodes. Overall, error was lowest for model predictions using the NV conductivity 
map; however, M1arm activation was approximately 10 percentage points lower than the 
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NV model predicted percent activation for subthreshold stimulation and threshold 
stimulation using electrodes where both experimental and model predicted percent 
activation were greater than zero. Alternatively, for suprathreshold stimulation, model 
predictions were 2-5 percentage points higher than M1arm percent activation. These 
results suggest that the overall shape of the model generated activation curve is 
inconsistent with the experimental results. In each of the presented models, the activation 
curve generated by model predictions increased gradually as stimulation amplitude 
increased in a near-linear manner. The experimental data suggest that the activation 
profile curve should rise more quickly at low stimulation amplitudes and rise more 
slowly at high stimulation amplitudes but not fully plateau within the range so 
stimulation amplitudes evaluated. However, the currently available experimental data are 
insufficient to define an experimental activation profile. Future validation studies may 
address this issue by collecting experimental data at motor contraction stimulation 
thresholds and at a range of sub/supra threshold stimulation amplitudes. Additionally, 
future work should incorporate more samples in order to allow for the distribution and 
variance of an experimental activation to be characterized and considered in the context 
of model validation. Assuming the true activation profile rises sharply at low stimulation 
amplitudes and levels off near the behavioral threshold, one consideration that could 
change the shape of the model generated activation profile is the anatomical 
representation of the CSTarm, which was generated by thresholding probabilistic 
tractography results. This procedure generates a single three-dimensional surface, which 
was uniformly populated with multi-compartment axons. The surface provides a 
convenient means to geometrically constrain the creation of a population of model axons; 
however, this may not capture the true distribution of axons that project from a single 
cortical region within the CST. Retrograde tracing studies have shown these topographic 
representations of CST fibers to be density distributed in one region of the CST, but then 
be more sparsely represented throughout the full extent of the CST [185]. This in mind, 
perhaps probabilistic tractography should be utilized seed the density, rather than simply 
the primary location, of different fiber projections within various CST topographical 
regions. It is reasonable to hypothesize that a CSTarm representation with graded axon 
density could generate an activation profile curve with a steeper accent at slow 
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stimulation amplitudes. However, extensive modeling would be required to show this 
effect, given the dependence of model outcomes on other parameters such as the brain 
tissue conductivity map. Comparisons between retrograde tracing studies and model axon 
trajectories generated using the proposed approach would provide valuable insight 
regarding the sensitivity of model outcomes to the anatomical representation of fiber 
tracts in the brain. 
Model predictions of activation during stimulation using the DBS array (Subject N) were 
zero at the motor contraction threshold for all configurations using any of the tissue 
conductivity maps. In order to make a comparison between the models and experimental 
data, the stimulation amplitude required to generate 10% activation in the model was 
selected as a conservative threshold for generating a stimulation induced motor 
contraction. Modeling results indicated that the stimulation amplitudes required to 
achieve 10% activation were larger than 1 mA in all directions but posterior, the direction 
of the electrode facing the CSTarm. Comparing the model predicted stimulation 
amplitudes required to achieve 10% activation to the stimulation amplitudes required to 
induce motor contractions, the model required much higher (an order of magnitude in 
some cases) stimulation amplitudes. The model also resulted in a higher degree of  
directional steering than was observed in the experimental results. The large difference in 
stimulation amplitude makes interpreting these results difficult; however, it should be 
noted that the degree of model predicted steering using the DBSAs is consistent with 
previous DBSA experimental work [101,110,112]. This finding suggests that shorting or 
capacitive coupling between densely distributed conductors may be responsible for the 
limited directional steering observed in vivo. Despite the potential advantages with 
DBSA, by design these devices have many more failure points than conventional leads. 
Additionally, size limitations associated with increasing the number of electrodes 
requires the dense packaging of insulated conductors, and in some cases, required 
manufacturing techniques such as thin-film microfabrication that have not be proven 
clinically viable for long-term implanted devices. These factors are important 
considerations, and although they must be considered by device manufacturers, 
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packaging and biocompatibility should be more thoroughly considered in early 
investigational studies of novel electrode designs for neural stimulation. 
3.5.3. Model validation 
To date, only one attempt at in vivo electrical field validation has been performed in the 
context of deep brain stimulation [86]. In this study, microelectrode recordings of tissue 
voltage during DBS were compared to FEA predictions using a homogenous tissue 
conductivity map and using a subject-specific inhomogeneous and anisotropic tissue 
conductivity map of the brain. The results of this study further established the importance 
of incorporating subject-specific inhomogeneous and anisotropic tissue properties into 
models of DBS to accurately predict stimulation-induced electric fields in the brain. Of 
particular interest, the study demonstrated very good alignment between the experimental 
measures of voltage in the brain during stimulation and FEA results using the SE tissue 
conductivity map. Our behavioral results in both animals suggest that the SE map 
produced overprediction of the stimulation threshold necessary to generate a motor 
contraction. Comparisons between the two studies are difficult to make because of 
several key differences: (1) Thalamus and STN were targeted rather than GPi, (2) DWI 
was captured at 3 Tesla rather than 7 Tesla, (3) a very low subthreshold stimulation 
amplitude, 0.03 mA, was used, (4) the model did not incorporate tissue capacitance, and 
(5) a 0.25 mm encapsulation layer was assigned a conductivity of 0.18 S/m rather than a  
0.1 mm encapsulation layer with a conductivity of 0.066 S/m.  
In an attempt to compare model results between studies we ran our DBS lead model 
using a 0.03 mA amplitude stimulation waveform and captured the peak voltage of the 
stimulation waveform in tissue. On average, the peak voltage was 54% higher in for the 
models using the NV and VC conductivity maps in comparison to the model using the SE 
conductivity map. Using the SE conductivity map, the peak potential in tissue ranged 
from 1 to 8 mV within a distance of 1 to 6 mm from the stimulation electrode. These 
values were similar to the in vivo peak voltage observed by Miocinovic et al. in thalamus, 
1 to 6 mV within a distance of 1 to 6 mm from the stimulation electrode. This comparison 
indicates that the SE conductivity map may best reflect in vivo voltage measures while 
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model predictions of cellular activation using the NV or VC conductivity maps more 
accurately reflect cortical recordings. However, it is not possible to conclude this using 
only the data provided especially for low stimulation amplitudes, where model 
predictions in our study are most similar. Additionally, clear differences in contrast 
between GP and thalamus were observable in the DWI suggesting a significant difference 
in conductivity between the two brain regions that could significantly affect the measured 
stimulation waveform amplitude. Although these experiments are extremely difficult to 
perform, full validation may require replication of the Miocinovic et al. for GPi 
stimulation using a range of stimulation amplitudes that include values near a behavioral 
threshold.  
3.5.4. Limitations 
There are several key limitations of this study. Although our models did include an 
inhomogeneous and anisotropic representation of the electric properties of brain tissue, 
our models excluded several tissue types including the skull, meninges, vasculature, and 
CSF surrounding the brain. We assumed that high conductivity pathways exist between 
the brain and cephalic chamber, which was used as ground, due to the presence of 
granulation tissue and residual fluid; however, stimulations were not conducted to 
confirm the validity of this assumption. The NV and VC conductivity maps assumed the 
ventricles to be isotropic and purely resistive. We observed that the lateral ventricles in 
both subjects to be extremely narrow and considered that the choroid plexus could take 
up large proportion, by volume, of the ventricles potentially invalidating the assumption 
that the ventricles were purely resistive, homogenous, isotropic, and non-reactive. 
Additionally, each of the conductivity maps relied on DWI imaging with 1.1 mm 
isotropic resolution to represent the anisotropy of fiber tracts within the brain. The size of 
myelinated axons within the rhesus macaque CST; however, are on the order of microns 
[121]. Due to the limitations associated with DWI resolution, therefore, our conductivity 
maps and probabilistic tractography are both too course to capture the precise directional 
contributions of individual fibers. 
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This study included one subject with each style DBS lead, only subject with a cortical 
array, and involved the targeting of a single brain region, GPi. It is therefore not possible 
difficult to generalize our findings to other targets or to other subjects. However, the 
difference in predictions between models using the SE and the other conductivity maps 
was large enough that variance due to factors such as model complexity and uncertainty 
in the conductivity values are unlikely to account for this difference [151,194]. 
Additional validation studies will be required to determine if the measures of model 
validity described here are generalizable across brain regions and across subjects. This 
validation study, being the first of its kind, outlines a technique and provides baseline 
measures of error for use in future validation studies and model optimization studies.  
Histological evaluation was not used to verify the locations of the DBS leads and the 
cortical recording array.  Currently, both subjects in this study are participants in parallel 
studies preventing histological confirmation of electrode locations. Although verification 
of lead location is commonly performed using fused preoperative MRI and postoperative 
CT, reports estimate DBS lead localization error to be in the range of 1-2 mm [198–201]. 
Computational modeling studies have demonstrated that lead misplacement within 1 mm 
can significantly impact model outcomes [87,100]. Additionally, the analysis of cortical 
activity relies on the assumption that neural recordings were captured from cortical layer 
V pyramidal cells. This assumption is reasonable given the electrode array depth of 
1.5mm and the fact that putative antidromic activity was observed on many recording 
channels; however, histological verification is required to verify, with absolute certainty, 
the cortical layer from which the microelectrode recordings originated. 
3.6.Conclusions 
Model predictions using the NV and VC conductivity maps aligned well with predictions 
of cortical activation from M1arm while predictions using the SE conductivity map 
strongly under predicted activation. This finding suggests that future DBS modeling 
studies should utilize tissue conductivity models that incorporate measures of 
conductivity rather than relying on the more commonly utilized scaled eigenvalue 
method. M1arm percent activation required to evoke motor contractions were within the 
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range of 8-16% for the four most distal electrodes, which were nearest to the CSTarm, and 
0% for the two most proximal electrodes. For brain targets within several millimeters of a 
stimulating electrode, the range of 8-16% activation establishes a soft benchmark for 
assessing meaningful behavioral outcomes from model generated activation profile 
curves. Model results using the DBS array suggest a much greater directional bias than in 
vivo behavioral outcomes. However, the model predicted directional bias seems 
consistent with the limited published data demonstrating directional thresholds for 
stimulation induced motor contractions. These findings suggest that more work is 
required to quantify, in vivo, the degree of current steering that is possible using DBS 
arrays and suggests that more comprehensive models that include highly conductive 
paths between electrodes and capacitive coupling between densely distributed conductors 
may be required to model current steering with DBS arrays.  
3.7.Supplement: Model complexity analysis 
Previous DBS modeling work has evaluated the impact of model complexity for human 
DBS leads with cylindrical shell electrodes [155,191,202]. In accordance with this work, 
an analysis was performed to determine the appropriate complexity for running models of 
GPi-DBS with small electrodes in the rhesus macaque brain. The analysis was performed 
using a model of the subject with the implanted DBSA, Subject N. The following 
parameters were varied in the complexity analysis: brain mesh element size, mesh 
element shape function order, inclusion of the ETI equivalent circuit model, inclusion of 
dielectric dispersion. The five models that were compared to evaluate complexity were 
labeled: standard model, fine resolution, cubic shape order, ETI, and dielectric dispersion 
(Supplementary table 1).  
Supplementary table 1. Details of model complexity study. 
Model label 
Mesh element size 
(mm) 
Shape 
function 
order 
Number of 
elements 
Conductiv
ity model 
ETI 
Maximum Minimum 
Standard 5 0.1 Quadratic 271754 
Median 
frequency 
No 
Fine resolution 2 0.04 Quadratic 464111 
Median 
frequency 
No 
Cubic shape 5 0.1 Cubic 271754 Median No 
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function frequency 
ETI 5 0.1 Quadratic 342858 
Median 
frequency 
Yes 
Dielectric 
dispersion 
5 0.1 Quadratic 271754 
Frequency 
dependent 
No 
The results from models of varying complexity were compared by calculating the mean 
difference (MD) between the standard model activation profile and the activation profile 
from each of the other models. The mean difference was calculated within 0-1 mA at 
0.025 mA increments using both the NV and VC conductivity maps. The SE conductivity 
map did not produce activation within 0-1 mA. Although the standard model was selected 
as the basis for comparison, but it was not assumed to produce results that represented the 
true activation profile. Therefore, variation in activation profile that could be attributed to 
complexity was considered in the context of the model validation results. 
Overall, electrode-tissue interface and finite element model complexity (beyond the 
standard model parameter settings) was found to have a minimal effect on the activation 
profile (Supplementary figure 1). For both the VC and NV tissue conductivity models, 
the activation profiles from the fine resolution mesh and the cubic shape order models 
differed on average by less than one percentage point from the standard model, with the 
fine resolution model predicting slightly lower activation and the cubic shape order 
model predicting slightly higher activation. The ETI and dielectric dispersion models 
differed by as much as 2.62 percentage points on average from the standard model. 
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Supplementary figure 1. Activation profiles from models with varied complexity differed 
by up to 2.62 percentage points on average in comparison to the standard model. 
Previous studies have evaluated the extent to which complexity affects model results and 
have concluded that highly complex models are necessary to achieve accurate results 
from models of DBS [118,194]. Examples of these highly complex models include those 
with higher order shape functions than what are mathematically required to solve the 
model [118], equivalent circuit models of the electrode tissue interface [118], and fully 
incorporated models of dielectric dispersion [191]. In such studies, error is commonly 
quantified with respect to the most complex model and using voltage predictions from the 
entire head or brain model or using a waveform reconstructed at a single point within the 
model. Calculations which use these techniques may generate measures of error that (1) 
are heavily biased by errors far from the stimulating electrode, (2) are too local and 
therefore not representative of error throughout the models, and (3) may have no bearing 
on the model outcome measure of interest, such as percent activation of a particular 
axonal pathway or VTA. Our results indicate that the general shape of percent activation 
curve for a population of axons within approximately 1 cm of the stimulating electrode 
was not affected by increasing model complexity by increasing mesh resolution, 
increasing shape order, including a model of the ETI, or including dielectric dispersion. 
Further, our results suggest that our standard model could have been further simplified by 
using a more coarse mesh. 
In previous studies, it has been assumed that more complex models generate superior 
results [118,194]; however, variance in model outcomes must be considered in the 
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context of the model goals, outcome measures, and the certainty of input parameters 
[86,181,203]. The simplest model we evaluated was selected as a reasonable predictor of 
the activation profile based on our findings that varying model complexity produced 
activation profile curves that were extremely similar in shape, and the range of values 
within the curves was approximately centered on the values predicted by the most simple 
model. Although these findings are specific to the models presented here, they have 
important implications. For example, assessing the precision of models, which use a 
similar framework where complexity is limited by computational resources and 
knowledge of electrode material properties, the former being highly relevant to models 
used in clinical practice and research studies that do not focus on model development. 
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4. Computational modeling of endovascular DBS 
Teplitzky BA, Connolly AT, Bajwa JA Johnson MD (2014) Computational modeling of 
an endovascular approach to deep brain stimulation. Journal of neural engineering, 11(2), 
026011. © IOP Publishing.  Reproduced with permission.  All rights reserved. 
 
4.1.Overview 
4.1.1. Objective 
Deep brain stimulation (DBS) therapy currently relies on a transcranial neurosurgical 
technique to implant one or more electrode leads into the brain parenchyma. In this study, 
we used computational modeling to investigate the feasibility of using an endovascular 
approach to target DBS therapy. 
4.1.2. Approach 
Image-based anatomical reconstructions of the human brain and vasculature were used to 
identify 17 established and hypothesized anatomical targets of DBS, of which five were 
found adjacent to a vein or artery with intraluminal diameter ≥ 1 mm. Two of these 
targets, the fornix and subgenual cingulate white matter (SgCwm) tracts, were further 
investigated using a computational modeling framework that combined segmented 
volumes of the vascularized brain, finite element models of the tissue voltage during 
DBS, and multi-compartment axon models to predict the direct electrophysiological 
effects of endovascular DBS. 
4.1.3. Main results 
The models showed that: (1) a ring-electrode conforming to the vessel wall was more 
efficient at neural activation than a guidewire design, (2) increasing the length of a ring-
electrode had minimal effect on neural activation thresholds, (3) large variability in 
neural activation occurred with suboptimal placement of a ring-electrode along the 
targeted vessel, and (4) activation thresholds for the fornix and SgCwm tracts were 
comparable for endovascular and stereotactic DBS, though endovascular DBS was able 
to produce significantly larger contralateral activation for a unilateral implantation. 
4.1.4. Significance 
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Together, these results suggest that endovascular DBS can serve as a complementary 
approach to stereotactic DBS in select cases. 
4.2.Background 
The use of neuroendovascular techniques to deliver therapeutic electrical stimulation to 
deep brain structures has been proposed several times within the literature [204–207]; 
however, the feasibility of this technique has never been investigated in the context of 
known deep brain stimulation (DBS) targets and current state-of-the-art endovascular 
technology. Previous studies have established proof-of-concept demonstrations for 
navigating recording electrodes to cerebral capillaries in baboons [205] and humans 
[204]. A number of more recent studies have described recording neural activity using 
electrodes placed within larger vessels in the brain, including the middle cerebral artery 
[208–210], callosomarginal artery [210], basilar artery [210], middle meningeal artery 
[210–212], middle cerebral artery [209,210,213], and cavernous sinus [214,215]. Most 
recently, a study comparing endovascular sinus and subdural surface recording electrodes 
found similar results using the two modalities during seizure monitoring in an 
anesthetized swine model [62]. Endovascular electrodes have also been used to 
electrically stimulate cranial nerves, including the parasympathetic efferents of the vagus 
nerve from within the superior vena cava for cardiac rhythm management [216], and the 
phrenic nerve from within the brachiocephalic vein for respiratory maintenance [217]. 
Surprisingly, while many studies have focused on recording neural activity from within 
the vasculature, little is known about the mechanistic feasibility of electrically stimulating 
brain tissue using an endovascular electrode. 
In this study, we developed a computational modeling framework to investigate the 
proximity of major blood vessels to known DBS targets and to estimate the intensity of 
stimulation necessary to modulate these DBS targets using endovascular electrodes. A 
three-dimensional reconstruction of the brain—including the parenchyma, vasculature, 
and ventricles—was coupled with a multi-compartment cable model of myelinated axons 
in the context of an inhomogeneous finite element model of the tissue voltage generated 
around a stimulating electrode [98,122,164]. Models of transvascular electrical 
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stimulation were generated for two clinical DBS targets: (1) the fornix for memory 
disorders [218], and (2) the subgenual cingulate white matter (SgCwm) for treatment-
resistant depression [219,220]. 
4.3.Methods 
4.3.1. Human subject imaging 
Retrospective data analysis was performed using anatomical T1-weighted magnetic 
resonance imaging (MRI) (Figure 24a) and gadolinium enhanced magnetic resonance 
angiography (MRA) (Figure 24b) from a single subject (51-year-old female). The 
subject's data showed no evidence of vascular damage/deformity in the deep cerebral 
veins or anterior cerebral arteries (ACAs); thus our analysis was constrained to these 
areas. Both imaging datasets were captured in the sagittal plane using a clinical 1.5 T 
scanner with slice thickness = 0.9 mm, field of view = 23 × 23 cm, matrix = 256 × 256 
voxels. 
 
Figure 24. Image alignment and reconstructed anatomical surfaces. Sagittal T1-weighted 
MRI from a single subject (a). Sagittal gadolinium contrast enhanced MRA (b) aligned 
by three-dimensional co-registration to the MRI. Surface reconstructions of the brain 
anatomy (c), including ventricles (green), cerebral veins and sinuses (blue), ACAs (red), 
cerebellum (orange), thalamus (yellow), and brainstem (pink), overlaid onto the MRI. 
4.3.2. Anatomical surface reconstructions 
Three-dimensional surface representations of the cranial anatomy were constructed for 
the purpose of generating axonal tracts and anatomically correct boundaries to regions 
with different electrical conductance values. In order to establish a common coordinate 
system for the entire analysis, the subject MRA was co-registered to the subject MRI in 
three dimensions. Surface representations of the ventricles and brain areas were 
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reconstructed from the subject MRI in reference to the Mai human brain atlas [221] and 
surface representations of the cerebral veins and arteries were reconstructed from the 
MRA in reference to the Cerefy human cerebral vasculature atlas [222]. All surfaces were 
constructed using Mimics Innovation Suite (v15.0, Materialise, Leuven, Belgium). Image 
resolution enabled reconstruction of cerebral vasculature ≥1 mm in diameter. Surface 
reconstructions of the cerebral veins, arteries, ventricles, and brain regions were 
combined into a single three-dimensional anatomical model (Figure 24c). 
4.3.3. Electrode construction and placement 
Three-dimensional electrode models were digitally constructed and oriented within the 
anatomical model using Rhinoceros3D (v4.0, McNeel, Seattle, WA). An endovascular 
guidewire electrode, a compliant endovascular ring-electrode, and a clinical DBS lead 
were investigated. The cylindrical (diameter = 0.127 mm; length = 1 mm) guidewire 
electrode was constructed to model the exposed metallic tip of a 4 French (Fr) 
endovascular guidewire. An annular ring-electrode, which was morphed to the retaining 
vessel shape, was constructed (0.5–4.5 mm length; 0.1 mm wall thickness) to model a 
compliant endovascular snare or tightly meshed stent-style electrode. Only the macro 
features of each electrode were modeled. The primary coils of a guidewire, the primary 
coils of a snare, and the individual struts of a stent were not modeled because two-
dimensional simulations incorporating these fine features showed the effect to be 
negligible in the tissue conductance model solution. In each rendition, the stimulating 
surface of the endovascular ring-electrode was created by sectioning and radially scaling 
the internal wall of the encapsulating vessel to 75% of its original diameter. This method 
produced electrodes that maintained the intraluminal shape of the surrounding vessel and 
that could be nested within the finite element mesh used to calculate the tissue voltage 
during stimulation. Because the model electrodes were inspired by actual endovascular 
devices, the surface areas of each electrode were not equal. The clinical DBS lead model 
was designed to replicate the quad-contact 3387 DBS lead (Medtronic Inc., Minneapolis, 
MN) with an electrode contact diameter of 1.27 mm, length of 1.5 mm, and inter-
electrode spacing of 1.5 mm. 
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Model fornix and SgCwm tracts were targeted bilaterally using both endovascular and 
stereotactic approaches. Endovascular electrodes targeting fornix and SgCwm were 
positioned within the ipsilateral internal cerebral vein (ICV) and the ipsilateral A2 
segment of ACA, respectively. For both endovascular targets, the electrode was initially 
placed within the vessel at the midpoint of the shared vessel/target border. Clinical DBS 
leads targeting the SgCwm were introduced through the superior frontal gyrus along a 
slight lateral to medial paracoronal trajectory [219]. For this trajectory, the active contact 
resided at the sagittal midpoint between the anterior commissure and the anterior aspect 
of the genu of the corpus callosum. Clinical DBS leads targeting the fornix were 
introduced through the superior frontal gyrus and lateral ventricles parallel to the anterior 
aspect of the fornix such that the ventral tip of the lead lay in close proximity to optic 
tract [218]. In this trajectory, the lead was external to the fornix and the three most 
ventral contacts were at equal distances from the target. The two most ventral contacts 
were in, or in close proximity to, the hypothalamus, and the more dorsal of the two center 
contacts was set as the active contact. 
4.3.4. Axon models 
Bilateral surface reconstructions of the fornix and SgCwm tracts were independently 
populated with 400 three-dimensional, multi-compartment axon cable models [75]. Axon 
geometries were bound by contours generated from cross-sections of the anatomical MRI 
reconstructions of each target. Each contour was populated with 500 uniformly 
distributed seed points using a Jordan curve algorithm [223], and the closest points from 
adjacent contours were connected using a nearest neighbor algorithm [87] in Matlab 
(vR2011b, Mathworks, Natick, MA). Fornix axon seed points were bounded by 16 
contours (~1 mm separation) along the axial centerline of the tract in each hemisphere. In 
fornix only, axons were allowed to cross hemispheres to reflect anatomy described in 
retrograde labeling studies [224]. SgCwm axon seed points were bounded by five 
parasagittal contours (1 mm separation) in each hemisphere. Spline fits were applied to 
each set of connected points resulting in 500 three-dimensional traces, of which the 400 
shortest length splines were used to create axon cable model compartments. The 2 µm 
diameter myelinated axon cable model consisted of nodes of Ranvier, myelin attachment 
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segments, paranode main segments, and internode segments with each compartment 
connected through an axial resistance. These axonal equivalent circuit models included 
membrane capacitance, linear leakage properties, and nonlinear sodium and potassium 
conductances that were consistent with previous studies [96,98–100,122,164]. 
4.3.5. Predicting tissue voltage during DBS 
Separate three-dimensional tissue conductance models of the brain were developed for 
each simulation. Anatomical surface reconstructions of the cerebral vasculature, 
ventricles, electrodes, and an implantable pulse generator (IPG) were nested within a 
cylindrical boundary (radius = 30 cm; height = 55 cm) and combined to form a single 
non-manifold assembly surface mesh. The model IPG was a 76 × 61 × 13 mm3 
rectangular cuboid with rounded edges and was centered 33 cm below and 3.75 cm to the 
right of the geometric center of the head model. The resulting nested surface mesh was 
transformed to a volumetric mesh of tetrahedral elements using 3-Matic (Materialise Inc., 
Leuven, Belgium). Depending on electrode complexity, each volumetric mesh consisted 
of between 95,300 and 115,000 elements, with finer resolution near the electrode surface 
and more coarse resolution near the model perimeter. The conductance of blood, 
cerebrospinal fluid (CSF) and bulk tissue were modeled as 0.7 S/m [82]
 
, 1.8 S/m [183], 
and 0.3 S/m [79,80], respectively. The model assumed ideal electrode behavior, isotropic 
conductances, and linear scaling of electric potentials in the tissue. Voltage sources were 
specified at the surface of each electrode and the IPG surface was set to ground while the 
outer surface of the bounding cylinder was assigned the condition of zero-flux. The tissue 
voltage solution (Figure 25a) for each electrode configuration was calculated by solving 
Poisson's equation using the finite element method (FEM) with Comsol Multiphysics 
(v4.0a, Comsol Inc., Burlington, MA). 
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Figure 25. Modeling tissue and extracellular axonal cable model voltages during DBS. 
The FEM tissue voltage solution superimposed onto the anatomical surface mesh of the 
cranium, ventricles, and major blood vessels from 1 V stimulation applied across an 
endovascular ring-electrode in the ICV (a). The FEM solution from (a) superimposed 
onto a bilateral subpopulation (20/400) of model axons representing the fornix tract (b). 
The FEM solution from 1 V applied across a single contact of a clinical DBS lead 
targeting the fornix superimposed onto a bilateral subpopulation (20/400) of model axons 
representing the fornix tract. 
4.3.6. Predicting axonal responses to DBS 
Thresholds for driving axonal action potentials were calculated using the Neuron v7.2 
programming environment [124]. Each axonal compartment of each axon was perturbed 
using the inserted extracellular mechanism by driving the variable, e_extracellular with 
the calculated peri-stimulation extracellular membrane potential. Conductance values 
required for the application of extracellular stimulation in this manner were assigned 
values consistent with previous work [122]. The applied extracellular membrane potential 
was consistent with a 130 Hz voltage-controlled stimulation waveform and scaled 
according to the FEM solution (Figure 25b and c). The voltage waveform was derived 
from an experimental recording of a voltage-controlled IPG (Medtronic, Minneapolis, 
MN), which exhibited a charge-balanced 90 µs cathodic pulse followed by a 400 µs 
interphase delay and a 3 ms anodic pulse. Electrical capture of axonal output with DBS 
was defined by axonal action potentials occurring within 1 – 3 ms following the 
application of the stimulus with a probability ≥ 0.8. The percentage of the neural 
population activated by stimulation amplitudes between 0 and 10 V was calculated at 
0.125 V increments and used to generate an activation profile for each simulation. 
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Activation plots were calculated for unilateral and bilateral stimulation of each target 
using both endovascular electrodes and stereotactic leads for delivering DBS. 
4.4.Results 
4.4.1. Endovascular stimulation targets 
Seventeen known or hypothesized therapeutic targets for DBS were investigated in the 
context of the human neural vasculature. For each target, adjacent blood vessels with 
intraluminal diameters of ≥1 mm (Table 7) were identified using a three-dimensional 
atlas [222] of idealized cerebral blood vessels joined with T1-weighted anatomical MRI 
from a single subject. No large cerebral arteries or veins (≥1 mm diameter) were found 
directly adjacent to the following 12 targets: anterior limb of the internal capsule, 
centromedian/parafasicularis nucleus of the thalamus, globus pallidus internus, 
hippocampus, hypothalamus, inferior thalamic peduncle, lateral habenula, periaqueductal 
gray/periventricular gray, subthalamic nucleus, ventralis caudalis nucleus of the 
thalamus, ventrolateral intermedus nucleus of the thalamus, and the ventral 
posterolateral/ventro-posteromedial nucleus of the thalamus. Either the ICV or the A1/A2 
segments of the ACA were found to directly border some aspect of the remaining five 
targets (Table 7). The dorsal aspect of the ICV was found to border the ventral aspect of 
the ipsilateral fornix, and the ventral aspect of the ICV was found to border the dorsal 
aspect of the ipsilateral anterior nucleus of thalamus. The dorsal border of the A1-ACA 
was found to border the ventral aspect of the ipsilateral nucleus accumbens and the A2-
ACA was found to border the medial aspect of the subgenual cingulate and ventral 
capsule. 
Table 7. Adjacent blood vessels to known and putatively therapeutic DBS targets. 
Targeted neural region Clinical disorder(s) [13–17] 
Adjacent 
blood 
vessels [222] 
Intraluminal 
vessel diameter 
[222] (mm) 
Anterior limb of the internal capsule TRD, OCD -  
Anterior nucleus (Thal.) Epilepsy ICV 0.4-1.4 
Centromedian/parafasicularis (Thal.) PD, ET, TS, Epilepsy, DoC -  
Fornix AD ICV 0.4-1.4 
Globus pallidus internus PD, dystonia, TRD, TS -  
Hippocampus Epilepsy -  
Hypothalamus Aggressive behavior, obesity, AM -  
Inferior thalamic peduncle TRD, OCD -  
Lateral habenula TRD, obesity, AM -  
Nucleus accumbens TRD, OCD, addiction, obesity,AM A1-ACA 2.2-2.6 
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Periaqueductal gray/periventricular 
gray 
Chronic pain -  
Subgenual cingulate white matter TRD A2-ACA 1.9-2.2 
Subthalamic nucleus PD, dystonia, TRD, OCD, epilepsy -  
Ventralis caudalis nucleus (Thal.) Chronic pain -  
Ventral capsule OCD A2-ACA 1.9-2.2 
Ventrolateral intermedus (Thal.) ET -  
Ventral posterolateral/ventro-
posteromedial (Thal.) 
Chronic pain -  
A1 = A1 segment and A2 = A2 segment of the ACA = anterior communicating artery, AD 
= Alzheimer's disease, AM = anorexia mentosa, ICA = internal carotid artery, ICV = 
internal cerebral vein, Thal. = thalamus, TRD = treatment resistant depression, OCD = 
obsessive-compulsive disorder, PD = Parkinson's disease, ET = essential tremor, TS = 
Gilles de la Tourette Syndrome, DoC = disorder of consciousness. 
4.4.2. Endovascular navigation to the fornix and SgCwm 
Theoretical endovascular implantation paths from the internal jugular to the ICV (to 
stimulate fornix) and from the internal carotid artery to the A2-ACA (to stimulate 
SgCwm) were characterized using the Cerefy human cerebral vasculature atlas [222]. 
Overall path length, vessel branching angles, and intraluminal vessel diameters were 
measured for right-sided endovascular access to each target. Fornix and SgCwm were 
selected for further investigation because (1) each is directly adjacent to a ≥1 mm 
diameter vessel, (2) each has shown potential efficacy in long-term (≥12 month) clinical 
trials [218,225], (3) together they include both venous and arterial approach paths, and 
(4) they present two extremes of relative axon-to-vessel angle. 
The approach path to fornix was characterized by navigation through the right internal 
jugular vein, sigmoid sinus, transverse sinus, straight sinus, great cerebral vein of Galen, 
basal vein, and terminated in the ICV (Figure 26a, left). This implantation path would 
involve maneuvering through the large diameter, yet highly tortuous, sigmoid sinus and 
through four obtuse branching angles. The proposed electrode target was within a 1 mm 
diameter section of the ICV at the most anterior aspect of the shared ICV/fornix border 
(Figure 26a, right). At the site of the endovascular electrode implantation, the right ICV 
also bordered the ventral edge of the interventricular foramen and the dorsomedial aspect 
of the anterior thalamus. The approach path to SgCwm was characterized by navigation 
through the right internal carotid artery, A1-ACA, and terminated in the A2-ACA. 
Catheterization of the A2-ACA would require maneuvering through the tortuous carotid 
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artery and two slightly obtuse branching angles (Figure 26b, left). The proposed electrode 
target was within a 2 mm diameter section of the A2-ACA just beneath the genu of the 
corpus callosum (Figure 26b, right). 
 
Figure 26. Endovascular targeting of the fornix (a) and SgCwm (b). Vascular 
reconstructions with estimated path length, vessel diameter, and vessel branching angles 
(left). Combined vascular and brain reconstructions (center). Ring-electrode model 
implant location (right). 
4.4.3. Optimizing model features and electrode geometries 
Pilot simulations were run to evaluate model sensitivity to tissue conductance 
homogeneity and multi-compartment axon population size. For endovascular stimulation, 
the addition of blood to an otherwise homogenous bulk neural tissue conductance model 
resulted in activation of an additional 5–25% of the axonal population. The inclusion of 
CSF resulted in activation of an additional 2–20% of the axonal population for fornix and 
resulted in no change in the activation profile for SgCwm. For stereotactic DBS, the 
predicted activation was not affected by the inclusion of blood or CSF in the tissue 
conductance model. Sensitivity to the number of axons for each target was evaluated by 
quantifying activation using 100, 200, 300, 400, and 500 axons in the model. For both 
targets, the amplitude-dependent activation predictions differed by ≤5% of the total 
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population for models containing 300, 400, or 500 axons. Final model parameters 
included inhomogeneous tissue conductance models consisting of bulk neural tissue, 
blood, and CSF with 400 multi-compartment axons per target, per hemisphere. 
Transvascular electrical stimulation from endovascular electrodes that utilized passive 
radial force for securing contacts against the vessel wall have been shown experimentally 
to drive behavioral effects with lower stimulation amplitudes in comparison to guidewire 
electrodes [226]. To evaluate this effect for endovascular SgCwm and fornix stimulation, 
model predictions of neural activation were calculated for ring-electrodes and free-
floating guidewire electrodes at stimulation amplitudes from 0 to 10 V. Endovascular 
electrodes targeting SgCwm and fornix were positioned within the ipsilateral A2-ACA 
and the ipsilateral ICV, respectively, at the midpoint of the shared vessel/target border. 
Predicted activations were calculated using a 1 mm long endovascular ring-electrode and 
1 mm long guidewire electrode, placed at five different locations within the target vessel 
(Figure 27). The model-predicted activation from an endovascular ring-electrode was 
consistently higher than guidewire electrodes in both targets. In SgCwm, predicted 
activation from guidewire electrodes increased with stimulation amplitude, but at a 
slower rate in comparison to the ring-electrode. The predicted SgCwm activation 
increased at approximately the same rate for each guidewire electrode. Guidewire 
stimulation activated axons at lower amplitudes for electrodes placed closer to the neural 
target (Figure 27a). In fornix, the predicted activation from the ring-electrode increased 
sharply between 1 and 2 V and increased at a slower rate between 2 and 10 V (Figure 
27b). The activation profile of the guidewire nearest to the fornix mimicked that of the 
ring-electrode, with a sharp increase between 2 and 4 V and slower increase between 4 
and 10 V. The models predicted much lower levels of activation from all other guidewire 
electrodes targeting fornix. 
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Figure 27. Ring-electrodes produced higher estimates of axonal activation than guidewire 
electrodes. Stimulation through a ring-electrode within the right A2-ACA produced 
approximately four times greater activation in the right SgCwm than guidewire electrodes 
for stimulation at high amplitudes (a). Stimulation through a ring-electrode within right 
ICV produced approximately two times greater activation in the right fornix than 
guidewire electrodes for stimulation at high amplitudes through all electrodes but the 
most dorsal, which produced nearly equivalent levels of activation for amplitudes beyond 
4 V (b). 
Previous modeling work has shown electrode length to be an important factor for 
optimizing the volume of tissue activated by DBS [227]. To evaluate the effect of 
electrode length in endovascular stimulation in these two targets, model predictions of 
neuronal activation of SgCwm and fornix were calculated for ring and guidewire 
electrodes measuring 0.5, 1.5, 2.5, 3.5, and 4.5 mm in length at stimulation amplitudes 
between 0 and 10 V. For all electrodes, the longitudinal midpoint was centered at the 
midpoint of shared vessel/target border, and guidewire electrodes were placed along the 
intraluminal wall closest to the shared vessel/target border (Figure 27a blue, Figure 27b 
yellow). Stimulation through longer electrodes yielded a ≤10% increase in the predicted 
levels of activation in both targets across the stimulation amplitude range (Figure 28). 
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Figure 28. Endovascular ring-electrode length effect on predicted neural activation of the 
SgCwm (a) and fornix (b). 
Precise lead implantation is known to be vital for delivering therapeutic stereotactic DBS. 
To determine the optimal location within each target vessel for delivering endovascular 
DBS, and to evaluate neural activation sensitivity to sub-optimal endovascular electrode 
placement, the location of a 1 mm long endovascular ring-electrode was systematically 
varied in 1 mm increments along the target vessel length from 5 mm posterior/ventral to 
5 mm anterior/dorsal to the midpoint of the shared vessel/target border. Predictions of 
neural activation were generated at stimulation amplitudes between 0 and 10 V for each 
target at each location. For both targets, the models predicted the optimal ring-electrode 
placement to be anterior to the midpoint of the shared vessel/brain target border and that 
1 mm deviations from the optimal location resulted in a minimal reduction in the 
predicted activation (Figure 29). For the SgCwm, the highest levels of activation were 
achieved using electrodes placed 0–2 mm dorsal to the midpoint of the shared 
vessel/brain target border. For the fornix, the optimal location was 3–4 mm anterior to the 
midpoint of the shared vessel/brain target border. Fornix stimulation at this placement 
involved delivery of current through the CSF-filled intraventricular foramen (Figure 26a). 
In both targets, across the entire stimulation amplitude range, placement of the 
endovascular electrode 1 mm away from the optimal location decreased the predicted 
neuronal activation by 1–10% of the total population, and placement 5 mm away from 
the optimal location decreased the predicted neuronal activation by 30–60% of the total 
population. 
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Figure 29. Endovascular ring-electrode placement effect on predicted neural activation of 
the SgCwm (a) and fornix (b). Asterisks (*) indicate optimal axial placements. 
4.4.4. Comparing endovascular DBS to stereotactic DBS 
To compare endovascular to stereotactic DBS, endovascular ring-electrodes and 
stereotactic DBS leads were placed within the model and stimulation was delivered using 
both unilateral and bilateral configurations. Ring-electrodes were placed anterior to the 
midpoint of the shared vessel/target border, in accordance with previous model 
predictions of optimal placement (Figure 30a and b, left). Stereotactic DBS leads were 
placed along the clinical implantation trajectory described previously (Figure 30a and b, 
right). 
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Figure 30. Comparison of predicted neuronal activation for stimulation delivered using 
unilateral and bilateral endovascular ring-electrodes (left) and stereotactic leads (right). 
Activation profiles for all stimulation configurations (center) were predicted for the 
SgCwm (a) and fornix (b). 
For SgCwm, unilateral stimulation through an endovascular ring-electrode activated 10% 
less of the neuronal population than unilateral stimulation through the stereotactic DBS 
lead at low amplitudes, but activated 10% more of the neuronal population at high 
amplitudes, with an inversion in the activation profiles occurring at 4.25 V. With the 
endovascular electrode, the contralateral SgCwm was also activated, but at 10% less of 
the total population than the ipsilateral SgCwm. Contralateral activation was not 
achievable with a stereotactic DBS electrode (Figure 30a). At amplitudes below 1.25 V, 
bilateral stereotactic DBS activated a larger portion of the neural population than bilateral 
endovascular DBS. Above 1.25 V, however, bilateral endovascular stimulation activated 
10–30% more of the total population than bilateral stereotactic DBS. 
In the fornix, unilateral stereotactic DBS activated 10–30% more of the ipsilateral 
neuronal population than did unilateral endovascular stimulation across the 0–10 V range. 
Unlike in the SgCwm, unilateral stereotactic DBS activated a small portion of the 
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contralateral fornix axons at large amplitudes, and remained significantly lower than the 
activation resulting from unilateral endovascular DBS. Neuronal activations from 
bilateral stimulation were comparable between endovascular and stereotactic DBS at 
amplitudes below 5 V. Above this threshold, stereotactic DBS activated more of the 
neural population than endovascular stimulation. 
4.5.Discussion 
This study provides a theoretical foundation for evaluating an endovascular approach to 
targeting DBS therapy. The purpose was to formally examine the feasibility of using an 
endovascular approach to implant electrodes within two vascular targets to modulate 
neural activity in nearby brain regions: the fornix and SgCwm, both of which are current 
targets of stereotactic DBS therapies. 
4.5.1. Opportunities for neuroendovascular targeting 
Neurovascular disorders including intracerebral aneurysm and ischemic stroke are 
routinely treated with endovascular techniques that deliver conductive devices, such as 
platinum aneurysm coils, Nitinol stents, and tungsten snares for mechanical occlusion or 
recanalization of the neural vasculature [228]. In these procedures, wire-guided 
microcatheters under fluoroscopic navigation enable device deployment to sub-millimeter 
diameter cerebral blood vessels by way of tortuous implantation trajectories in the 
presence of acute branching angles [229]. Several of these vascular targets are 
noteworthy given their proximity to established and investigational targets of DBS 
therapy. For example, the anterior communicating artery (ACoA), which demarcates the 
A1 and A2 segments of the ACAs, is a common target of neuroendovascular intervention 
that necessitates a complex implantation path [230], and it lies just proximal to the A2 
segment of the ACA, the proposed vascular target for delivering endovascular DBS to the 
SgCwm. The ACoA has an intraluminal diameter of approximately 1 mm [231] and 
current technologies in endovascular intervention allow for catheter-based implantation 
of devices such as aneurysm coils, stents, and balloons into this target [232–234]. 
Delivery of a coil- or stent-shaped electrode into the A2 segment of the ACA would 
require navigation through or around the ACoA to a point with an approximately equal 
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diameter that is approximately 2 cm distal to this more conventional target. To our 
knowledge, device implantation to within the deep cerebral veins, including the ICV, has 
not been described within the clinical literature. However, endovascular thrombolysis for 
the treatment of deep cerebral vein thrombosis involves catheter navigation to the straight 
sinus and/or great cerebral vein of Galen [235–239], 2–3 cm proximal to the ICV. 
Neuroendovascular navigation to deep cerebral veins may increase risk due to veins 
generally having thinner walls than arteries [240]; however, current technologies enable 
device implantation to arteries with equivalent diameters [233,241]. Navigating 
endovascular devices to neurovascular targets that are several centimeters distal to 
commonly catheterized vessels may increase targeting complexity, require novel designs 
for endovascular devices, and carry higher risk for some patients. 
4.5.2. Transvascular stimulation feasibility 
Although limited, in vivo demonstrations have established feasibility for delivering 
transvascular electrical stimulation. Direct, low frequency vagal nerve electrical 
stimulation (20 Hz) has been shown to induce acute bradycardia in humans [242–246], 
and subsequent studies have reproduced this effect with transvascular stimulation in 
canine and porcine models [247,248]. These studies show comparable degrees of cardiac 
modulation through direct vagal nerve stimulation using a nerve-cuff and transvascular 
vagal nerve stimulation using a multipolar diagnostic catheter. Studies investigating 
endovascular electrode design factors evaluated the use of a basket electrode [249–252] 
and a flexible-loop electrode lead [226,253]. They found that transvascular stimulation 
thresholds for modulating neural activity could be greatly reduced by using bipolar 
stimulation from electrodes that conform to the vessel wall, in comparison to monopolar 
stimulation delivered through a guidewire or diagnostic catheter, thus minimizing 
electrode-to-target proximity and securing the electrode within the vessel. 
4.5.3. Electrode design for neuroendovascular stimulation 
Our comparison of guidewire electrodes placed at different radial positions within the 
vasculature confirmed that target-to-electrode proximity plays a large role in neural 
activation thresholds. This result is somewhat surprising, considering that the relatively 
 98 
high conductive environment of the blood could cause the voltage distribution within the 
vessel to be relatively uniform. These results indicated that electrical stimulation in the 
presence of blood and blood vessel walls may not differ fundamentally from intra-
parenchymal stimulation, and principles such as current steering may apply to 
transvascular electrical stimulation in the same manner as stimulation through 
stereotactically-placed DBS leads [87,100]. The models also indicated that, in 
comparison to guidewire electrodes, a ring-electrode ensured close proximity to the 
neural target and allowed for lower stimulation charge densities given the ring-electrode's 
larger surface area. Existing stents and some snare designs would fall into such a 
category [254]. 
When designing electrodes for endovascular DBS, several other specifications must be 
considered, given that the human neurovasculature is replete with small vessel diameters, 
tortuous vessels, and acute vessel branching angles that can impede navigation and 
deployment of endovascular devices. The models showed that, assuming a vascular 
implant position proximal to the neural target, increasing the length of the ring-electrode 
did not have a significant effect on neural activation thresholds. This is noteworthy 
because longer electrodes impose challenges with navigability through tortuous vessels. 
While shorter length designs provide similar activation levels to longer ones, 
misplacement due to migration of the electrode along the vessel, larger charge densities 
due to smaller surface area, and higher neural activation threshold sensitivity to off-target 
implantations may limit practical implementation of small device length designs. Though 
not specifically modeled in this study, mechanical and electrochemical material 
properties of endovascular devices, as well as their ability to migrate into the intimal 
layer of the vessel, will also have important implications in terms of electrode material 
sustainability and biocompatibility [255,256]. 
4.5.4. Comparison to current stereotactic DBS procedures 
The model simulations also compared stimulation threshold amplitudes between 
endovascular and stereotactic DBS, showing comparable thresholds for unilateral DBS 
cases and potential for significant contralateral activation with unilateral endovascular 
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DBS cases targeting midline structures. Bilateral activation from unilateral stimulation 
could be advantageous because it would reduce potential complications resulting from 
implantation of two devices. While the target areas modeled in this study were limited to 
midline structures in close proximity to vessels with intraluminal diameters ≥1 mm, other 
targets may be accessible provided that neurovascular targeting techniques are advanced; 
however, charge density limits with small endovascular electrodes may limit the overall 
volume of tissue activation and therefore reduce the ability to deliver effective therapy 
with stimulation. 
The low surgical complication rates for stereotactic DBS [257] reflect years of experience 
perfecting the surgical procedure and the strict patient selection criteria. Indeed, 
complications associated with craniotomy, meningeal damage, micro bleeds, ventricular 
penetration, and risk of severe hemorrhage can disqualify patients from surgical 
candidacy. Risk factors for the occurrence of hemorrhage in DBS surgery have been 
studied extensively and are correlated with the use of microelectrode recording, sulcal 
incursion, and breaching the ventricular walls during implantation [36–41]. The reported 
symptomatic effects of clearly observable vascular events following DBS surgery include 
increased relative risk of post-operative seizure [42], permanent neurological deficit [43], 
post-operative confusion [44], and subsequent extended hospital stays [45]. Reports on 
the symptomatic effects of small bleeds exist, but remain difficult to interpret as small 
bleeds are likely underreported [38] due to a lack of blood-sensitive pre- and post-
operative imaging [36,46]. Increased risk of hemorrhage has been shown to vary across 
anatomical targets [51,52] and may relate to lead trajectory and target proximity to large 
blood vessels. For example, GPi-DBS for PD carries a higher risk of hemorrhage than 
STN-DBS [52–54,258] and this may be related to the close proximity of the A1 segment 
of the ACA to the ventral border of GPi. Alternatively, reports of cognitive complications 
with STN-DBS are higher in comparison to GPi-DBS and are correlated with the use of 
transventricular [44] and transcaudate [259] lead implantation trajectories. 
For those cases that do not fit the selection criteria for stereotactic DBS or that seek to 
target heavily vascularized brain regions, endovascular DBS approaches may provide a 
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suitable alternative. However, further study is needed to evaluate risks associated with 
endovascular targeting procedures, including vessel wall damage, vasospasm, occlusion, 
and hemorrhage. While there is the possibility that thrombosis and vasoconstriction could 
occur with electrical stimulation [260], some studies have shown that cathodic electrical 
stimulation can prevent thrombosis formation due to the effect of the applied negative 
charge on blood cells [261,262]. Since the clinical DBS waveform utilizes a large 
amplitude cathodic pulse followed by a low amplitude anodic pulse, the likelihood of 
stimulation-induced clot formation may not be significant, but still needs to be verified. 
4.5.5. Model limitations 
The computational modeling approach used here made several assumptions worth 
discussing. While the reconstructions were specific for the two DBS targets, anatomy of 
the cerebral veins, arteries, and sinuses can differ significantly among subjects [263–
267]. While our models showed that inhomogeneity of the vessel wall did not have a 
large effect on the parenchymal tissue voltage during endovascular DBS, studies 
performing simultaneous subdural and endovascular EEG from within arteries and 
venous sinuses suggest that the vessel wall acts as a low-pass filter but does not 
completely attenuate high frequencies [62,209,214,215]. The traditional DBS tissue 
conductance model did not include the low conductance encapsulation tissue which can 
reduce the volume of tissue activated by up to 50% [91]. Also, because diffusion tensor 
MRI was not available in the patient data, anisotropic conduction was not included in the 
tissue conductance model. The effect of higher conduction along the fiber tracts is 
difficult to estimate in general terms; however, based on the axon-to-electrode orientation 
slightly lower than predicted voltages would likely occur within the fornix tract and 
slightly higher than predicted voltages would occur within the SgCwm. Additionally, the 
absolute neural activation percentages calculated by the models are based on the 
excitability of multi-compartment axons, which are in turn determined by model 
parameter assumptions [96,268] that do not fully represent the true diversity of neuronal 
membrane dynamics and cellular morphologies. 
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Scaling of the ring-electrode was also required in order to properly generate an 
inhomogeneous mesh with which to perform the finite element modeling. In reality, a 
stent would tightly conform to the vessel wall, securing it in place and reducing the 
electrode-to-target proximity. The modeling of the ring-electrode in this study did not 
include the mesh structure of a stent that would be required for insertion using an 
endovascular technique or the primary coils of an endovascular snare that would increase 
the electrode surface area. Modeling these features in a two-dimensional setting, we 
found that due to the high conductance of blood and the reduction in the scaling of the 
stent-electrode, the effects of the lattice structure and primary coils were negligible. Even 
so, it is worth noting that a stent-electrode with a large free cell area may result in higher 
charge densities at the lattice struts. 
4.6.Conclusions 
Endovascular delivery of DBS electrodes may provide a complementary technique for 
treating a number of neurological disorders. This study investigated endovascular DBS 
through a computational modeling approach. The models predicted that activation of 
neural targets using an endovascular device is feasible using current catheter technology 
for midline thalamic and cortical targets. In comparison to endovascular guidewire 
designs, endovascular ring-electrode designs were found to allow for reduced electrode-
to-target distance, more robust anchoring to the vessel wall, and increased predicted 
levels of neural activation. Using endovascular ring-electrodes to target specific neural 
structures (fornix and SgCwm), the models predicted neuronal activation comparable to 
that achieved following stereotactic DBS implantation, suggesting further research in this 
alternative targeting strategy for clinical DBS applications. 
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5. Conclusions and future directions 
Deep brain stimulation is a valuable therapy that provides to the means to target specific 
brain regions and disrupt pathologic activity. In the US, DBS is currently approved or 
granted exemption for the treatment of four disorders. However, ongoing studies are 
exploring many more applications and brain targets for DBS. These investigational 
applications are primarily composed of treating disorders for which medication is 
ineffective or not well tolerated by patients. In such cases, neurosurgical intervention 
could greatly benefit patient quality of life by reducing symptoms and improving the 
efficacy of pharmaceutical intervention, as is the case for DBS to treat Parkinson’s 
disease. Successful implementation of DBS relies on the precise placement of stimulating 
electrodes within small and deep brain structures.  
Studies investigating complications associated with DBS have established suboptimal 
lead placement and lead migration to occur at a rate somewhere between 1-5% [269–
272]. However, the vast majority of these analyses are performed at academic centers by 
clinicians who specialize in DBS. In a recent study, which analyzed complication rates 
between 2004 and 2013 using data from the Centers for Medicare and Medicaid Services 
and the National Surgical Quality Improvement Program, it was estimated that 15-34% of 
DBS procedures were performed for the purpose of revising the lead placement or lead 
removal [273]. The authors highlight the contrast between the occurrence of suboptimal 
placement within academic centers and the nationwide occurrence. These data suggest 
that suboptimal lead placement is, by far, the most prevalent complication in DBS. 
Additionally, these data suggest that this complication rate is likely to increase over time 
due to the increasing popularity and applications of DBS and due to an increase in the 
number of non-academic clinical practices performing DBS surgery. For these reasons it 
is imperative that next-generation DBS technology be able to compensate for suboptimal 
lead placement, or be delivered using novel methods that improve targeting success. 
Computational models of DBS can facilitate the process of designing and evaluating 
next-generation DBS technologies by enabling high-throughput studies which explore the 
impact of changing lead design features within a large design feature parameter space. 
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Models can also generate predictions of stimulation efficacy and be used to guide 
programming of next-generation DBS technologies which may offer an increasingly 
complex assortment of stimulation configurations.  
This thesis leverages computational modeling to prospectively evaluate novel electrode 
designs and to retrospectively evaluate model parameters in the context of experimental 
data. These studies show how independent current controlled stimulation with advanced 
machine learning algorithms can negate the need for highly dense DBS arrays to shift, 
steer, and sculpt regions of modulation within the brain. Additionally, these studies show 
that while advanced and personalized computational models of DBS can predict many of 
the behavioral and electrophysiological outcomes of DBS, there are remaining 
inconsistencies that suggest there are additional physiological mechanisms of DBS that 
are not yet well understood. Finally, the results show how computational models can be 
beneficial for prospective development of novel approaches to neuromodulation prior to 
large-scale preclinical and clinical studies.  
5.1.Designing deep brain stimulation arrays 
In the past five years, several novel DBS array designs have entered clinical trials. These 
innovative designs and clinical trials are motivated by the need for DBS leads that can 
radially steer current in order to compensate for suboptimal lead placement. Recent 
publications describing clinical demonstrations using DBS arrays have shown improved 
short-term outcomes in single patients [110,112]. However, studies have not 
demonstrated that current DBSA designs are optimal, nor have studies demonstrated that 
any single design is maintains equivalent efficacy when used to target brain regions with 
different geometry and cellular makeup. The computational modeling study in chapter 2 
takes a first step toward optimizing DBSA lead design by comparing electrode charge 
storage capacity, electrode charge injection limit, and radial steering capacity for DBS 
leads and DBS arrays with different numbers of electrodes. In this study, radial steering 
capacity was evaluated using groups of electrodes in a single plane within a population of 
lead-parallel axons. A natural extension of this work to be considered in future studies is 
the ability of DBSA leads with different designs to steer current in three-dimensions in 
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the context of specific brain targets with anatomically correct electrical properties and 
distributions of cells and fiber pathways. This work also demonstrated the successful 
classification of stimulation settings using various machine learning algorithms that could 
feasibly be used to guide programming of stimulation parameters in patients implanted 
with a four radial electrode DBSA. Perfect classification was achieved using only a 
simple feature set to consisting of the RoA center of mass and orientation. Again, a 
natural extension of this work to be considered in future studies is classification accuracy 
using three-dimensional representation of features in subject-specific models. This work 
will be crucial for determining the degree to which machine learning classification for 
programming DBSAs is generalizable and clinically applicable. Therefore, in order 
expand on this work, personalized models of DBS were created using various proposed 
methods and a validation study was conducted in a preclinical model of DBS. 
5.2.Validation of computational models of DBS 
Personalized models of deep brain stimulation rely on a model framework that includes 
volume conductor models of the brain and multi-compartment cell models to predict 
cellular responses to stimulation. Outcome measures from computational models of DBS 
include activation curves and spatial activation profiles. Although certain aspects of these 
models have been validated, no studies have directly compared model predicted cellular 
responses to experimentally acquired measures of cellular responses during stimulation. 
Additionally, the imprecise relationship between model results and behavioral outcomes 
limit the usefulness of personalized computational modeling results.  
While a limited number of studies have attempted to relate model predictions of cellular 
activation to behavioral outcomes [100,148], no current studies have established a robust 
guideline for relating percent activation to the occurrence of some side-effect. The study 
detailed in chapter 3 compared model predictions of activation to cortical recordings of 
activation at the stimulation threshold for inducing a motor contraction. Results from this 
study suggest that although results from one of the models aligned with experimentally 
acquired cortical recording data, no percent activation threshold was found to be 
consistently predictive of motor contractions induced by stimulation. This finding may be 
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related to the conventional technique for modeling the distribution of fibers within the 
corticospinal tract and suggests the new for novel techniques to determine personalized 
anatomically correct fiber distributions that can be directly incorporated into models of 
the brain. 
The commonly proposed use-case for the spatial activation profile, RoA in two-
dimensions and volume of tissue activated (VTA) in three-dimensions, is to superimpose 
the spatial activation profile onto preoperative patient imaging and select the stimulating 
electrode and amplitude that precisely fills the targeted brain region. Spillover into 
nearby brain regions that might induce side-effects is avoided, but some spillover is 
generally unavoidable due to the axisymmetric VTA generated by conventional DBS 
being superimposed onto brain targets with asymmetric geometry. To address this issue, 
deep brain stimulation arrays with thousands of electrodes have been proposed [71,133]. 
In chapter 2, we used computational modeling to show that leads with radial four 
electrodes around the lead provide a reasonable balance between electrode surface area, 
which allows for safe stimulation at conventional amplitudes with capacity to steer and 
shift a RoA. However, in chapter 3, our results indicated that model predictions of radial 
current steering may significantly over predict the capacity to steer current, although 
comparisons with recent studies suggest that issue related to lead design may be 
responsible for the lack of current steering observed in vivo. This contradiction illustrates 
the need for model validation and suggests the need for incremental advancement of deep 
brain stimulation arrays that can leverage conventional manufacturing and materials in 
their construction.  
As DBS arrays enter the market, clinical programing and hardware design will rely on 
computational modeling more than ever. Validation of these model outcomes will be key 
for regulatory body acceptance and integration into clinical practice. Studies on 
computational models of DBS have been established that model predictions are sensitive 
to the electric parameters of tissue [190], which are not well established and are subject to 
significant uncertainty [151].  Further, it remains unclear how precisely to interpret model 
outcomes in the context of behavioral effects. In Chapter three, we demonstrate a first 
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attempt at model validation by comparing model predictions of cellular activation to in 
vivo cortical recordings and behavioral outcomes. We found that one model aligned best 
with the cortical recording data and was, in general, consistently predictive across 
electrodes. However, behavioral outcomes were not consistently associated with a 
specific percent activation. This finding suggested, in the case of the two most proximal 
electrodes, that stimulation of circuits other than the CSTarm/M1arm were responsible for 
driving the upper limb motor contractions that were observed. Currently we can only 
speculate as to which circuits may be involved, but future validation work might 
circumvent this issue using functional imaging such as fMRI or PET to gain a more 
complete picture of brain regions that are modulated by stimulation. Functional imaging 
may also play a role in validating the relationship between therapeutic effectiveness and 
model predictions of spatial activation profile coverage of the targeted brain region (STN, 
GPi, and VIM Thalamus). It should be noted, however, that electrophysiological studies 
have provided evidence that the therapeutic effect of stimulation may be related to 
stimulation driving action potentials in a manner that disrupts information flow, termed 
an information lesion [7,8]. Stimulation therefore, may not simply have the effect of 
suppressing or enhancing overall activation in a particular brain region, making 
functional imaging measures difficult to interpret.  
5.3.Endovascular DBS 
Although several studies investigating endovascular neural stimulation have been 
conducted in the past several decades, this method for delivering stimulation has yet to be 
translated into clinical practice. Previous studies investigating the endovascular 
electrodes for stimulating neural tissue have relied on custom electrodes, which were 
used for stimulating cranial nerves [216,217]. In the past five years, a growing interest in 
endovascular electrodes has been motivated by the prevalence of neuroendovascular 
procedures, the need for less invasive cortical recording devices for use in epilepsy 
monitoring prior to resection surgery, and the need for less invasive neural stimulation 
technologies. In addition to the computational modeling study in chapter 4, experimental 
work by Bower et al. and Oxley et al. have demonstrated the feasibility of delivering 
recording and stimulating electrodes to the brain using an endovascular approach 
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[62,64,274]. Together this work establishes an exciting foundation for endovascular 
approaches to neural stimulation; however, such electrodes currently exist only as a 
research tool. Continued research focusing on device refinement and endovascular 
stimulation efficacy in preclinical models are required before these devices can be 
evaluated in human subjects and validated personalized computational models of 
endovascular DBS may help to drive these efforts forward.  
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6. Appendix I: Immunohistochemical markers of neural activation for DBS  
6.1.Introduction 
Deep brain stimulation (DBS) is an enabling technology used to treat a range of brain 
disorders; however, its therapeutic mechanisms remain poorly understood. Current 
hypotheses are primarily supported by single-cell electrophysiological recordings in 
preclinical animal models of DBS. While electrophysiological recordings provide cell-
specific high-resolution temporal data, broad spatial cell sampling is generally 
impractical. Immunohistochemistry (IHC) complements electrophysiology by providing 
broad spatial sampling of single-cells at a single time point, but is extremely 
underutilized in preclinical animal model studies of DBS. In this study we hypothesized 
that unilateral electrical stimulation of the anterior limb of the internal capsule would 
drive cellular activation and increase the number of cells expressing the immediate-early 
genes cFos and EGR-1 in the non-human primate. 
6.1.1. Methods  
A small-diameter (0.635 mm) 8-electrode version of a clinical DBS lead was 
stereotactically implanted into the anterior limb of the internal capsule ALIC of an 
anesthetized rhesus macaque. Charge-balanced monopolar current-regulated 100 sec 
digital pulses were delivered at 130 Hz through an electrode in the ALIC for 1.5 hours. 
Transcardial perfusion with 25mM phosphate buffered saline (PBS) followed by 4% 
paraformaldehyde in 25mM PBS (PFA) was performed 1 hour after stimulation was 
stopped. The brain was postfixed, cryoprotected, and sectioned at 50 m in the coronal 
plane using a freezing microtome. Blockface photos were captured during sectioning 
through the entire brain so that three dimensional reconstructions could be used to verify 
lead location. Immunohistochemistry (IHC) was performed using the avidin-biotin-
peroxidase complex method on free-floating sections. Primary antibody incubations were 
performed for 48 hours at 4°C and consisted of a polyclonal anti-cFos primary antibody 
(1:1000, Abcam, Cat #: ab7963) or a monoclonal anti-EGR1 antibody (1:1000, Cell 
signaling, Cat #: 15F7). Secondary antibody incubations were performed for 45 minutes 
at room temperature using a biotinylated goat anti-mouse antibody (1:200, Vector 
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laboratories, BA-9200).  Sections were processed using the Vector laboratories ABC kit 
and reacted with a solution of 3% H2O2, 73µg/ml DAB in 0.05 M Tris. Section images 
were captured using a transparency scanner and microscopy was performed using a Leica 
TCS SPE. 
6.1.2. Results 
The final DBS lead location was visually confirmed to be in the anterior limb of the 
internal capsule. More specifically, most distal electrode, which was used to deliver 
stimulation, was confirmed to in the ALIC directly between the thalamus and putamen 
(Figure 31). 
 
Figure 31. DBS lead and implant location. Visual inspection using three-dimensional 
reconstructions of blockface images from sectioning confirmed the lead location. The 
location of the stimulating electrode within the ALIC was confirmed through visual 
inspection of reconstructed blockface images. 
ALIC stimulation resulted in unilateral staining of cFos and EGR-1 -like expression in 
two cortical regions: SMA and M1 (Figure 32 and Figure 33). Expression was only found 
in the hemisphere ipsilateral to stimulation and was completely lacking in the non-
stimulated hemisphere. The location and region where expression was detected was 
comparable between cFos and EGR-1; however, more background staining was observed 
in the case of cFos. Expression of cFos and EGR-1 were also detected in the basal 
ganglia and limbic system, but with no clear hemispheric-bias in expression. 
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Figure 32. Results of cFos staining. cFos-like immunoreactive cells was observed 
ipsilateral to electrical stimulation. Brain regions with the most prominent staining 
included primary motor cortex (top) and supplementary motor area (middle and bottom). 
 
 134 
 
 
Figure 33. Results of EGR-1 staining. EGR-1-like immunoreactive cells were observed 
only ipsilateral to electrical stimulation. Brain regions with the most prominent staining 
included primary motor cortex (top) and supplementary motor area (middle and bottom). 
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6.1.3. Discussion 
IHC can produce whole-brain analysis that provide detailed information about the spread 
and network effects of DBS. ALIC stimulation resulted in unilateral cFos and EGR-1 
expression in two cortical regions: SMA and M1. Studies using anterograde tract-tracer 
labeling have demonstrated the existence of white matter projections through the ALIM 
to M1 and SMA in the rhesus macaque [185].  Immunohistochemical staining using 
antibodies targeting both cFos and EGR-1 generated results that are in alignment with 
anterograde tract-tracer labeling and suggest that increased cFos and EGR-1 expression 
in the brain hemisphere ipsilateral to stimulation identified cortical cells that are actively 
driven by DBS within the ALIC. Further, these results demonstrate that IHC can be a 
powerful tool for determining which brain regions are driven during deep brain 
stimulation.    
7. Appendix II: Endovascular neural stimulation in a rabbit 
7.1.Introduction 
Although transvascular brain stimulation has never been formally investigated, 
demonstrations of transvascular VNS in dogs [247] and transvascular brain recording in 
pigs [62] provide a basis for developing such a technique. The goals of this work include 
development of a rabbit model of transvascular neural stimulation by determining a 
vascular approach to from the rabbit femoral vein/artery to the brain and demonstrating 
transvascular neural stimulation in the periphery.  
7.2.Methods 
7.2.1. Subject and imaging 
CT angiography was performed on one New Zealand White rabbit. Anesthesia was 
initiated by intramuscular injection of ketamine-xylazine (34 mg/kg-5 mg/kg) and 
maintained with isoflorine (1.5-3.0%) delivered via nose cone. In each animal, the 
femoral vein was catheterized, standard CT was captured, and CT angiography was 
captured at 10, 20, and 30 seconds following contrast injection (Figure 34a). The 
skeleton, veins, arteries, and the brain were reconstructed using a combination of 
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thresholding and dynamic region growing using Mimics Innovation Suite (v15.0, 
Materialise, Leuven, Belgium). 
7.2.2. Surgical procedure and stimulation protocol 
An endovascular approach was used to implant a 36 AWG 316 stainless steel Teflon 
insulated wire electrode (Cooner Wire Company, Chatsworth, CA) to the internal jugular 
vein in an anesthetized New Zealand White rabbit. The electrode was prepared by 
removing precisely 1 mm of insulation from the distal tip of the transvascular guidewire. 
Using a femoral approach, a 4 french endovascular catheter was placed adjacent to the 
vagus nerve in right side internal jugular vein, just distal of the internal and external 
branches. Transvascular electrical stimulation was delivered using an external waveform 
generator and dual current isolation units (S88X and SIU-C, Grass Technologies, West 
Warwick, RI) using a monopolar, charge-balanced, repeating waveform (135 Hz, 90 µs 
cathodic pulse width). A veterinary patient monitor (BM5Vet, Bionet America, Inc, 
Tustin, CA) was used to record SpO2 and EKG before, during, and after a 15-second 
transvascular stimulation block. 
7.3.Results 
7.3.1. Anatomical rabbit reconstructions 
The endovascular trajectory for reaching the sigmoid sinus in the rabbit was found to 
require navigation through the external jugular vein as opposed to the internal vein as in 
humans. In alignment with previous reports on rabbit vascular anatomy [275,276], the 
external jugular vein was found to follow the lateral edge of the neck and enter the skull 
near the base of the skull at the mandibular joint (Figure 34b). Reconstructions estimated 
the diameter of the sigmoid sinus to be approximately 2 mm in diameter. 
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Figure 34. Vascular reconstruction of the New Zealand white rabbit. Radiopaque CT 
angiography (a) in a single subject and subsequent reconstructions of the skeleton (b), 
veins, arteries, and the brain (c). 
7.3.2. Transvascular vagus nerve stimulation 
Respiration rate was observable within the SpO2 and EKG traces and stimulation 
artifacts were observable within the EKG trace, only. No clear behavioral outcome was 
observed during low amplitude, ≤ 2 mA stimulation (0.1 mA shown); however, counts of 
the visible cardiac R-waves during stimulation indicate the occurrence of stimulation 
induced bradycardia (Figure 35, top). Moderate stimulation amplitudes, 3-5 mA 
increased respiration rate (Figure 35, bottom) and high stimulation amplitudes, ≥ 5 mA 
produced visible neck muscle contractions. The cardiac rhythm and repertory pattern 
observed during low and moderate stimulation were rhythmic, but neither was 
synchronized to stimulation frequency.  
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Figure 35. Endovascular vagus nerve stimulation in the rabbit. Low amplitude 
transvascular electrical stimulation delivered via endovascular internal jugular vein wire 
electrode produced no clear behavioral effect (top). Moderate amplitude stimulation 
modulated respiration rate. 
7.4.Discussion 
Bradycardia and altered respiratory patterns are commonly reported effects of 
transvascular vagus nerve stimulation (VNS) in healthy anesthetized animal preparations 
[75, 128]. These data indicate that the effects of low and moderate electrical stimulation 
were a result of successful neuromodulation through transvascular VNS in an 
anesthetized rabbit preparation. 
